syndrome	score	normalized_score
DRAVET SYNDROME	2.9179	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	86.3888704205079
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	2.333333	79.96617430343741
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	1.6684777039999998	57.18077055416566
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.50235294	51.48747181191953
MYOCLONIC-ASTASTIC EPILEPSY	1.344235154	46.06858199389972
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	1.31295385	44.99653346584873
LENNOX-GASTAUT SYNDROME	1.23257131	42.24172555605058
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	40.90935261660783
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	1.164156114	39.897053154666025
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	39.48443263991227
MYOPATHIC EHLERS-DANLOS SYNDROME	1.1036118	37.822125501216625
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.09399367	37.49250042839028
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	1.074447264	36.82262120017821
HYPEREKPLEXIA-EPILEPSY SYNDROME	1.0686936999999999	36.625439528427975
SLC35A2-CDG	1.045923054	35.84506165392919
BENIGN OCCIPITAL EPILEPSY	1.027027	35.197470783782855
ROLANDIC EPILEPSY	1.021574	35.01058980773844
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.001086973	34.30847434799
JOUBERT SYNDROME 1	1.000545554	34.289919256999895
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	34.27122245450495
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	34.27122245450495
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	34.27122245450495
HEREDITARY ANGIOEDEMA TYPE 1	1.0	34.27122245450495
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	32.14260392748209
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.92074085	31.55491449329998
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.8807085139999999	30.182957400870485
LAFORA DISEASE	0.7819456600000001	26.798233661194697
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	26.40999006134549
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.75940841	26.025854552931904
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7509319039999999	25.735354330168953
EARLY MYOCLONIC ENCEPHALOPATHY	0.7191456140000001	24.645999314575555
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.673464634	23.08045628705576
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.6467644	22.165406628054424
CENTRALOPATHIC EPILEPSY	0.6047009	20.72383906233935
SPINOCEREBELLAR ATAXIA TYPE 10	0.58389163	20.010679941053496
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5698413	19.529157956064296
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.277973885328493
PERIORAL MYOCLONIA WITH ABSENCES	0.53122691	18.20579560642928
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	18.061859556530383
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	17.873126700709417
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5116122	17.533575516638678
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.508878884	17.439901435964224
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.376957743582714
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.500541419	17.154166318242574
PAROXYSMAL HEMICRANIA	0.5	17.135611227252475
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	17.135611227252475
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	17.135611227252475
PYKNOACHONDROGENESIS	0.5	17.135611227252475
INHALATIONAL ANTHRAX	0.5	17.135611227252475
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.5	17.135611227252475
CREST SYNDROME	0.5	17.135611227252475
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.4956707	16.98724082388019
EPILEPSY, JUVENILE ABSENCE	0.48251765999999996	16.536470064087187
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.47200919	16.176331951060696
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.43886191399999996	15.04033428150382
MYOCLONIC EPILEPSY OF INFANCY	0.43886191399999996	15.04033428150382
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.40080681999999995	13.736139689502725
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39264331	13.456366222283151
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.252567257274066
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.34826975000000004	11.935630076424827
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.83634990918126
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	11.817653106686315
SPINOCEREBELLAR ATAXIA TYPE 42	0.34166633	11.7093228006443
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	11.665075910757738
COG4-CDG	0.333878554	11.442426196922444
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.333874419	11.442284485417595
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.333874419	11.442284485417595
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	11.4237293944275
PLACENTAL INSUFFICIENCY	0.333333	11.4237293944275
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.4237293944275
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	11.4237293944275
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.32705855400000006	11.208696459782724
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.3269231	11.204054285616369
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32566591	11.16096884745879
JUVENILE MYOCLONIC EPILEPSY	0.3123459	10.70447582165256
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.31148864000000004	10.67509647349121
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.325282360601802
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.29551881399999996	10.12779101408547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.29416481	10.081387641797184
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.272710404	9.346118921141917
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.26704225000000004	9.151864354501527
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.26636899999999997	9.128791253984028
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.264957434	9.080415161588814
LANDAU-KLEFFNER SYNDROME	0.259858903	8.905682271496623
PALLISTER-HALL SYNDROME	0.25867328399999995	8.865049659001336
HYPEREKPLEXIA 1; HKPX1	0.2542735	8.714263682785564
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25235294	8.648443743788341
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	8.635136228109259
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.25157535000000003	8.621794783919944
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.25157535000000003	8.621794783919944
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.251086973	8.605057507111278
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.250541419	8.586360704616332
DYSTONIA 6, TORSION	0.25	8.567805613626238
HYPERPARATHYROIDISM 2	0.25	8.567805613626238
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.24566625000000003	8.419282703314028
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	8.329454539223416
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.23864513	8.178660337914254
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.040536139004079
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	7.742868158607218
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.225180394	7.717207375167072
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.220987194	7.573501285170842
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20986120000000003	7.192199869769356
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.2088473	7.157452277322733
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	6.972421261866411
KAGAMI-OGATA SYNDROME	0.201086973	6.891496384386031
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.8542444909009905
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.19816368	6.791311559683335
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.18796611400000002	6.441828506802838
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1853263	6.3513588539703205
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.18296851	6.270554508379314
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.242090338942391
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.14145392234141
PFAPA SYNDROME	0.17543893000000002	6.012506597210324
DISTAL 17P13.1 MICRODELETION SYNDROME	0.17422827000000002	5.971015799033552
UNILATERAL POLYMICROGYRIA	0.17035464	5.838261763597108
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	5.7304369238150725
PEMPHIGUS VULGARIS	0.166667	5.711881832824978
PITYRIASIS RUBRA PILARIS	0.166667	5.711881832824978
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	5.711881832824978
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	5.711881832824978
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.166616824	5.7101622399671
JUVENILE ABSENCE EPILEPSY	0.16503685	5.656014599540766
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.16323018399999997	5.594097947153774
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.466455327461531
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.466455327461531
EPILEPSY, IDIOPATHIC GENERALIZED	0.15622691	5.354087185989925
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.308504540936974
FEBRILE CONVULSIONS, FAMILIAL, 9	0.153624	5.2648822783508695
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.231906987902258
GLYCINE ENCEPHALOPATHY	0.15211625999999998	5.213210185407313
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.149118154	5.110461427739128
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.087676068405361
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.147513204	5.055457829260771
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.147513204	5.055457829260771
ALG11-CDG	0.14394397299999998	4.933135919668254
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.143329824	4.912088282669043
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.8958840261832135
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.8958840261832135
WHITE-SUTTON SYNDROME; WHSUS	0.13140643400000002	4.503459131567224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.131332514	4.500925802803386
SCHINZEL-GIEDION SYNDROME	0.12959710000000002	4.441451043558724
BILATERAL POLYMICROGYRIA	0.12400210399999999	4.249703691010658
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.067953116967682
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.049256314472737
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.042741355084136
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.11036213900000001	3.782245416223997
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.10732005400000001	3.6779894444634844
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.10721061000000001	3.6742386647931737
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.658756777134241
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.10615581300000002	3.638089482161829
16P12.1P12.3 TRIPLICATION SYNDROME	0.10515338	3.603734877823092
AICARDI SYNDROME; AIC	0.1036867	3.553469961273519
SPINOCEREBELLAR ATAXIA TYPE 29	0.10364975400000001	3.552203776688715
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.10310420000000001	3.5335069741937697
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.102248084	3.5041668323109088
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.102248084	3.5041668323109088
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.10038322400000001	3.4402558004044006
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.3912438397477636
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.372077658590082
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.3627557489975666
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.3627557489975666
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.3627557489975666
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.3627557489975666
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.3627557489975666
CONGENITAL MYASTHENIC SYNDROME	0.093803459	3.2147592103910347
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.093803459	3.2147592103910347
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.09333960000000001	3.1988621954145104
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.091474173	3.134931731724871
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.09126560300000001	3.127783782857535
3P25.3 MICRODELETION SYNDROME	0.09094050000000001	3.116642105623908
UNVERRICHT-LUNDBORG DISEASE	0.0909091	3.1155659892388363
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.09051070400000001	3.1019124712978514
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.08949380400000001	3.0670620651838654
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08868102000000001	3.0392069639124033
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.08867000000000001	3.0388292950409546
CHROMOSOME 1P36 DELETION SYNDROME	0.087616003	3.0027075293875733
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.08636980300000001	2.9599987319647694
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	2.9554285273655716
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	2.95357483121423
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.08528521300000001	2.922828506802838
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08346845400000001	2.860565954967614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.08293227300000001	2.842190376640735
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.082769773	2.836621302991878
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	2.8236352856506395
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.8150914698927316
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08184530000000001	2.8049384831556945
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.081596	2.796394667397786
BECKWITH-WIEDEMANN SYNDROME	0.08119660000000001	2.782706741149457
3MC SYNDROME 2	0.08095217400000002	2.7743299633297926
LOCKED-IN SYNDROME	0.08020053	2.748570204599198
TRISOMY 8P	0.07951369900000001	2.725031666609548
3MC SYNDROME 3	0.07936511000000002	2.719939339936256
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.708893724939169
TRICHOHEPATOENTERIC SYNDROME 1	0.07872815000000001	2.6981099420816346
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.07847085000000001	2.6892919565440905
3MC SYNDROME	0.07750715000000001	2.656264779464684
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.6549454744850753
DDOST-CDG	0.07746451900000001	2.654803762980226
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07746451900000001	2.654803762980226
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.654803762980226
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.6362486719901304
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.6362486719901304
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.6362486719901304
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.076642919	2.6266465266116046
WITTEVEEN-KOLK SYNDROME	0.076598343	2.625118852599472
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.07648424000000001	2.621208403303746
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.615206141403064
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07378154	2.5285835703759556
14Q12 MICRODELETION SYNDROME	0.07377506900000001	2.5283618012954525
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.07339324000000001	2.5152760546968715
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.07251557300000001	2.4851973336988937
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.07251557300000001	2.4851973336988937
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.07251557300000001	2.4851973336988937
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.4851973336988937
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.466642242708798
RABIES	0.07197001900000001	2.4665005312039483
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.4665005312039483
TOXIC EPIDERMAL NECROLYSIS	0.07142860000000001	2.4479454402138527
STEVENS-JOHNSON SYNDROME	0.07142860000000001	2.4479454402138527
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.4479454402138527
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07142860000000001	2.4479454402138527
3MC SYNDROME 1	0.07142860000000001	2.4479454402138527
WALDENSTRÖM MACROGLOBULINEMIA	0.07142860000000001	2.4479454402138527
ESOPHAGEAL ATRESIA	0.07142860000000001	2.4479454402138527
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07142860000000001	2.4479454402138527
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.4479454402138527
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.070386854	2.412243531306762
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069565194	2.384084238664793
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.3814284245519035
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06901964	2.365387436169848
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06901964	2.365387436169848
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06901964	2.365387436169848
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.3549772096370676
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.3549772096370676
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0677507	2.321899311148429
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.06772852	2.3211391754343875
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.303304396997841
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.2847493060077455
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.2847493060077455
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.2847493060077455
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.2847493060077455
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.2847493060077455
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.2847493060077455
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.2847493060077455
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.2847493060077455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.065624809	2.249042427773399
SMITH-MAGENIS SYNDROME; SMS	0.065329293	2.238914733198533
CRYPTOCOCCOSIS	0.06486894900000001	2.223138181568937
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.2212824291442477
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06295310399999998	2.157479831385585
PERLMAN SYNDROME	0.062933064	2.156793036087597
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.1453048425237333
ACROCRANIOFACIAL DYSOSTOSIS	0.06256898000000001	2.1443154323314717
PEHO SYNDROME	0.06185766399999999	2.1199377634600225
MENTAL RETARDATION, X-LINKED 98; MRX98	0.061319532999999996	2.101495356249357
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.061281214	2.1001821172761233
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.060566673	2.075693923712259
DOORS SYNDROME	0.059889654	2.0524916549573327
HYPERTELORISM, TEEBI TYPE	0.058779000000000005	2.014428184653347
2Q23.1 MICRODUPLICATION SYNDROME	0.058454094	2.003293258850543
7P22.1 MICRODUPLICATION SYNDROME	0.058454094	2.003293258850543
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05790854	1.9845964563555984
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	1.9801196065663662
AGNATHIA-OTOCEPHALY COMPLEX	0.057360650000000006	1.9658195962849998
OKAMOTO SYNDROME	0.057270004000000006	1.9627130470543888
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.057265869000000004	1.9625713355495393
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.056642573	1.941210219678536
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0565438	1.9378251482230369
DISTAL MONOSOMY 12Q	0.056212403999999994	1.9264678021865038
17Q21.31 MICRODUPLICATION SYNDROME	0.056101154	1.9226551286884404
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.056097019000000005	1.9225134171835911
CHIME SYNDROME	0.056097019000000005	1.9225134171835911
POLAND SYNDROME	0.055555600000000004	1.9039583261934956
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.9039583261934956
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.9039583261934956
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.9039583261934956
WILDERVANCK SYNDROME	0.055555600000000004	1.9039583261934956
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.9039583261934956
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.9039583261934956
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.9039583261934956
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.9039583261934956
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.9039583261934956
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.9039583261934956
GITELMAN SYNDROME	0.055555600000000004	1.9039583261934956
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.9039583261934956
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.9039583261934956
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.9039583261934956
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.9039583261934956
SIMPSON-GOLABI-BEHMEL SYNDROME	0.055311163	1.8955811713903834
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.055087123	1.8879030467116764
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.054872623999999995	1.8805519037664074
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05403463	1.8518328249768667
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.05398471	1.8501220055519378
ALPHA-MANNOSIDOSIS	0.05373259400000001	1.8414816820315982
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.7540395147194903
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.050958119	1.7463970321121358
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.050795713	1.740831179958189
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.050292604	1.7235890195003256
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.050141244	1.718401727269612
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.04977360300000001	1.7058022207752155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049726704000000004	1.7041949347133216
MONOSOMY 13Q14	0.04922215	1.6869032523390108
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.6819237808012613
PYRIDOXINE-DEPENDENT EPILEPSY	0.048970854	1.678291031221084
NORRIE DISEASE	0.048692619000000006	1.6687555776414547
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.664197196614003
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04826488	1.654096439219987
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.6465276397409097
DISTAL MONOSOMY 9P	0.048037674	1.646309811850989
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.047267973000000005	1.619931217656534
CARDIOFACIOCUTANEOUS SYNDROME	0.047023504	1.6115529661743035
16P13.11 MICRODELETION SYNDROME	0.046763204	1.602632166969396
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04674574	1.6020336543404505
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.046722419	1.6012344151615887
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.046722419	1.6012344151615887
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.046689294000000006	1.6000991809177836
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.046370323000000005	1.5891676548202476
PITT-HOPKINS SYNDROME	0.046295303	1.5865966277117105
NEURONAL CEROID LIPOFUSCINOSIS	0.046244349	1.5848503718427636
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.046103003999999996	1.5800063059049314
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.04607855	1.5791682374310292
ZECHI-CEIDE SYNDROME	0.045988494000000005	1.5760819082216666
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.045984359	1.5759401967168172
FRYNS SYNDROME; FRNS	0.045984359	1.5759401967168172
HUNTINGTON DISEASE	0.045702929999999996	1.566295280852668
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.04552748	1.5602823948730253
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.04528335000000001	1.551915761335207
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.04502774	1.5431556941636106
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5396521470920865
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.044863134	1.5375144453202645
20P12.3 MICRODELETION SYNDROME	0.044856663000000005	1.5372926762397618
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.044019719000000006	1.5086095822337986
ENDOCARDIAL FIBROELASTOSIS	0.044019719000000006	1.5086095822337986
TRISOMY 13	0.044019719000000006	1.5086095822337986
NOONAN SYNDROME	0.04385423	1.5029380719010248
KLEEFSTRA SYNDROME	0.043789673	1.5007256245930294
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.043478300000000004	1.4900544912437028
LAMELLAR ICHTHYOSIS	0.043478300000000004	1.4900544912437028
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.043268413	1.482861407176394
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.043244119	1.4820288220980842
LISSENCEPHALY 2; LIS2	0.042790883999999994	1.4664959045889165
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.4653192364371639
WEST SYNDROME	0.0426748	1.462517564001508
ALG13-CDG	0.0426748	1.462517564001508
VELOCARDIOFACIAL SYNDROME	0.04261387	1.460429418417355
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.04256882	1.4588854998457796
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.042350604	1.4514069707666473
NOONAN SYNDROME 7; NS7	0.042346469	1.4512652592617978
COG2-CDG	0.04221225399999999	1.4466655471400662
SARCOSINEMIA	0.04219884399999999	1.4462059700469514
TRICHOTHIODYSTROPHY	0.041856054	1.4344581377017718
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.4247043764351073
MERRF	0.041517359999999996	1.4228506802837655
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.04122263	1.4127499228897495
ABLEPHARON-MACROSTOMIA SYNDROME	0.041164200000000005	1.410747455361733
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.041086973	1.4081007916652388
DIENCEPHALIC SYNDROME	0.041030029999999995	1.4061492854450117
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.4061492854450117
LESCH-NYHAN SYNDROME	0.041030029999999995	1.4061492854450117
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.040545554	1.389545700675143
OCULO-PALATO-CEREBRAL SYNDROME	0.040545554	1.389545700675143
ACROCEPHALOPOLYDACTYLY	0.04051068	1.3883505260632647
MAL DE MELEDA	0.04051068	1.3883505260632647
SHPRINTZEN OMPHALOCELE SYNDROME	0.04042614	1.385453236916961
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04030501	1.3813019637410466
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.040273673999999995	1.3802280407142122
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.3799838925254466
SPONDYLO-OCULAR SYNDROME	0.04	1.370848898180198
WOLF-HIRSCHHORN SYNDROME	0.039817463	1.3645931320470202
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.03938994	1.3499413962096027
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.3468710373899038
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039120539999999995	1.340708728880359
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.038742149999999996	1.327740841015799
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.038742149999999996	1.327740841015799
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.038603953999999996	1.3230046951574763
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.038595194	1.3227044792487748
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3201720415367215
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.3181226224339422
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.3181226224339422
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.3181226224339422
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.3181226224339422
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.3181226224339422
LIP, HAMARTOMATOUS	0.0384615	1.3181226224339422
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.3181226224339422
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.3181226224339422
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.3181226224339422
BAZEX SYNDROME; BZX	0.0384615	1.3181226224339422
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.3181226224339422
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.3181226224339422
CYCLIC NEUTROPENIA	0.0384615	1.3181226224339422
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.3181226224339422
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.3181226224339422
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.298305630761849
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.2880000685424449
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.037551399	1.2869323486068749
FLYNN-AIRD SYNDROME	0.037472419	1.284225607457418
ATYPICAL RETT SYNDROME	0.037472419	1.284225607457418
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294000000005	1.271917954693444
CANAVAN DISEASE	0.037037	1.2693032660474999
MYOCLONUS AND ATAXIA	0.037037	1.2693032660474999
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.2693032660474999
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.2693032660474999
MCLEOD SYNDROME; MCLDS	0.037037	1.2693032660474999
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.2693032660474999
CHRISTIANSON SYNDROME	0.037037	1.2693032660474999
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.2693032660474999
AICARDI SYNDROME	0.036931	1.2656705164673223
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.036931	1.2656705164673223
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03657568	1.2534932657047877
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036388000000000004	1.2470612426745262
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.03588419	1.2297950580897221
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.035394252999999994	1.213004318174029
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.2120224819219303
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.035171673	1.2053762294801056
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.035161549	1.205029267623976
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.1933256794269855
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03463849	1.1871033962781452
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.034525439	1.183229000308441
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.034182473	1.1714751362281093
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.03411333	1.1691055210939374
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.033828774	1.1593534391171734
QAZI-MARKOUIZOS SYNDROME	0.033636919	1.1527783337331643
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.1427764145447068
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.03303113	1.1320172041536722
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03292872	1.1285074882621065
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.124221323554611
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.124221323554611
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.124221323554611
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.124221323554611
YOU-HOOVER-FONG SYNDROME; YHFS	0.032803653999999995	1.124221323554611
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.1240796120497618
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.032799519	1.1240796120497618
TUBEROUS SCLEROSIS-1	0.032799519	1.1240796120497618
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.1240796120497618
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.032799519	1.1240796120497618
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.1240796120497618
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.032799519	1.1240796120497618
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.1240796120497618
LEIGH SYNDROME	0.032799519	1.1240796120497618
SANDHOFF DISEASE	0.032799519	1.1240796120497618
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.032594934	1.1170682340039069
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.1055245210596663
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.1055245210596663
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.1055245210596663
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.1055245210596663
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.031911	1.0936289797457077
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03177888	1.0891010658350184
OTOONYCHOPERONEAL SYNDROME	0.03176474	1.0886164707495116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.031386759	1.0756625998149354
PEHO-LIKE SYNDROME; PEHOL	0.031385124	1.0756065663662222
15Q13.3 MICRODELETION SYNDROME	0.030669823000000002	1.0510923266732926
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.030622243000000004	1.0494617019089072
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.030472208999999997	1.0443198533191678
FG SYNDROME TYPE 1	0.030379793000000002	1.0411526440248124
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.030363614	1.040598169916721
EDINBURGH MALFORMATION SYNDROME	0.030130740000000003	1.0326172932588507
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.030059513	1.0301762568970836
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.0266751430823537
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.029930254000000003	1.0257463929538368
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.0182313650227903
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.029663389999999998	1.0166006374447376
11Q22.2Q22.3 MICRODELETION SYNDROME	0.029616953	1.015009184687618
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.0079783405874088
AREDYLD	0.0294118	1.0079783405874088
OSSIFIED EAR CARTILAGES	0.0294118	1.0079783405874088
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	1.0079783405874088
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.0079783405874088
HAIRY EARS, Y-LINKED	0.0294118	1.0079783405874088
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.0079783405874088
DARWINIAN POINT OF PINNA	0.0294118	1.0079783405874088
MUSICAL PERFECT PITCH	0.0294118	1.0079783405874088
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.0079783405874088
EAR FOLDING	0.0294118	1.0079783405874088
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	1.0079783405874088
OSTEOMA OF MIDDLE EAR	0.0294118	1.0079783405874088
EAR MALFORMATION	0.0294118	1.0079783405874088
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	1.0079783405874088
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.0079783405874088
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	1.0079783405874088
BLAU SYNDROME	0.0294118	1.0079783405874088
EAR WITHOUT HELIX	0.0294118	1.0079783405874088
ALKAPTONURIA	0.0294118	1.0079783405874088
EAR WAX, WET/DRY	0.0294118	1.0079783405874088
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029301533	1.0041993557010178
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.028886884	0.9899888275814799
CHROMOSOME 17Q12 DELETION SYNDROME	0.028832049999999998	0.9881095993694096
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.028678469	0.9828461907536242
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.9809794715377497
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.028529854	0.977752973028548
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	0.9712931903080982
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	0.9706759655916928
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.9706759655916928
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	0.9706759655916928
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9706759655916928
MENKES DISEASE	0.028319219000000003	0.9705342540868434
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.027807454000000002	0.9529954419274136
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.9519791630967478
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9519791630967478
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9519791630967478
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.9519791630967478
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9519791630967478
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9519791630967478
MENINGIOMA	0.027777800000000002	0.9519791630967478
CLEFT CHIN	0.027777800000000002	0.9519791630967478
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.9519791630967478
GANGLIOCYTOMA	0.027777800000000002	0.9519791630967478
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9519791630967478
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9519791630967478
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9519791630967478
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.9519791630967478
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9519791630967478
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9519791630967478
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9519791630967478
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.9519791630967478
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9519791630967478
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9519791630967478
DIMPLES, FACIAL	0.027777800000000002	0.9519791630967478
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9519791630967478
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9519791630967478
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9519791630967478
DWARFISM, LEVI TYPE	0.027777800000000002	0.9519791630967478
OROFACIAL CLEFT 3	0.027777800000000002	0.9519791630967478
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9519791630967478
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9519791630967478
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9519791630967478
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.9519791630967478
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9519791630967478
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9449451317728502
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.9448034202680009
ACROCALLOSAL SYNDROME; ACLS	0.027498869000000002	0.9424198567462903
NIEMANN-PICK DISEASE TYPE B	0.0271205	0.9294526885774016
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9262483292779053
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	0.9262483292779053
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9262483292779053
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9262483292779053
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.027026354000000002	0.9262261900681998
COHEN SYNDROME	0.026737663000000005	0.9163323965865864
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026439254	0.9061055553651599
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.026049203999999996	0.8927380650467801
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0258937	0.8874087528702149
TEMPLE-BARAITSER SYNDROME	0.025816269000000003	0.8847550978443401
7Q11.23 MICRODUPLICATION SYNDROME	0.025513389	0.8743750299873198
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.025513389	0.8743750299873198
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.025253849000000002	0.8654802769114776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.025247954000000003	0.8652782480551082
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.025243819	0.8651365365502588
PITT-HOPKINS-LIKE SYNDROME	0.025243819	0.8651365365502588
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.02497197	0.8558199389972241
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.024962793	0.8555054319887592
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.024954453999999997	0.8552196442647108
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.024628633	0.8440533602933616
RETT SYNDROME, CONGENITAL VARIANT	0.024555659	0.8415524521059666
MEHMO SYNDROME; MEHMO	0.024301243	0.8328333047739812
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.024093203	0.8257035196545461
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.024015693	0.8230471572020975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.023243814	0.7965939202851366
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0232415	0.7965146166763769
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02320945	0.7954162239967099
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.022989814	0.7878890297816923
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.022989814	0.7878890297816923
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.022900764	0.7848371774221187
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.022863704000000002	0.7835670859179548
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02262717	0.7754607765859007
DYSTONIA 12; DYT12	0.02261903	0.7751818088351211
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.02261903	0.7751818088351211
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02261903	0.7751818088351211
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.022533443	0.7722486377189075
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7715550224476506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.7700925323006271
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.7700925323006271
BETA-UREIDOPROPIONASE DEFICIENCY	0.022456554	0.769613557695603
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.769613557695603
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.022456554	0.769613557695603
ANGELMAN SYNDROME	0.022398513000000002	0.7676244216731212
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.022396883	0.7675685595805203
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.022396883	0.7675685595805203
9Q33.3Q34.11 MICRODELETION SYNDROME	0.022305499000000003	0.7644367181877378
SMITH-MAGENIS SYNDROME	0.022150543	0.7591261866410776
SCHAAF-YANG SYNDROME; SHFYNG	0.022064723	0.7561850303300319
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.022054003000000003	0.7558176428253196
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.022039853999999998	0.7553327392988107
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7528582199527057
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.021911	0.750916755200658
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.021911	0.750916755200658
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021873504000000002	0.749631721443504
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.021773243	0.7461956544089928
PELGER-HUET ANOMALY; PHA	0.021570044	0.7392317762774598
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.021503673	0.736957160971932
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.021503673	0.736957160971932
MELAS	0.02142389	0.7342229000308441
DUPLICATION/INVERSION 15Q11	0.021384049	0.7328575002570341
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.021318604	0.7306146201034992
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7295110867404639
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.021225353000000002	0.7274187943383942
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.021073984	0.7222311936666781
MENTAL RETARDATION, X-LINKED 104; MRX104	0.020988123000000004	0.719288632235512
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.020976349999999998	0.7188851571335548
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7188186709619933
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7188186709619933
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020962254	0.7184020699818362
MOWAT-WILSON SYNDROME; MOWS	0.020949749	0.7179735083450427
JOUBERT SYNDROME 3; JBTS3	0.020893210000000002	0.7160358476986874
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.020843524000000002	0.714333047739813
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.020843524000000002	0.714333047739813
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7108142842455191
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7108142842455191
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7108142842455191
AYMÉ-GRIPP SYNDROME	0.020722103999999998	0.7101718359093868
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.020666859000000003	0.7082785222248879
DISTAL MONOSOMY 10Q	0.020447503	0.7007609239521573
PEHO SYNDROME; PEHO	0.020432243000000003	0.7002379450975017
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.020346664	0.6973050481510675
TONNE-KALSCHEUER SYNDROME; TOKAS	0.020344684000000002	0.6972371911306077
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.020015543000000004	0.6859571267007095
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.019837003	0.679838342643682
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.019804814	0.6787351862640941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.019804814	0.6787351862640941
FRANK-TER HAAR SYNDROME	0.01980111	0.6786082456561227
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01980111	0.6786082456561227
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.019793533	0.6783485726035847
XQ12-Q13.3 DUPLICATION SYNDROME	0.01967596	0.6743192021659412
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6743192021659412
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6716576990301244
AASE-SMITH SYNDROME I	0.01956778	0.6706117413208129
SUPRABULBAR PARESIS, CONGENITAL	0.019500019	0.6682894890160732
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.019440183	0.6662388361492855
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.019299039	0.6614016587271668
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.6611117584564242
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.019240643999999998	0.6594003906919359
16P11.2P12.2 MICRODELETION SYNDROME	0.019215684000000004	0.6585449809794717
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.6582144693101203
PERMANENT NEONATAL DIABETES MELLITUS	0.019200004	0.6580076082113849
TRANSIENT NEONATAL DIABETES MELLITUS	0.019200004	0.6580076082113849
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.019190999	0.657698995853182
KEPPEN-LUBINSKY SYNDROME	0.019178729000000002	0.6572784879536654
DYSTONIA-APHONIA SYNDROME	0.019129043000000002	0.6555756879947908
SALT-AND-PEPPER SYNDROME	0.019082104	0.6539670310839988
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.018878884	0.6470024332567942
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.018878884	0.6470024332567942
COHEN SYNDROME	0.018836309000000002	0.6455433359607938
HSD10 DISEASE	0.018820953	0.6450170670687824
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.018820953	0.6450170670687824
DOWN SYNDROME	0.018699530000000002	0.6408557524246892
21Q22.11Q22.12 MICRODELETION SYNDROME	0.018681349	0.6402326673292437
WEAVER SYNDROME	0.018640153	0.6388208300490078
MARSHALL-SMITH SYNDROME	0.01863731	0.6387233969635697
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6352702285890538
AMISH INFANTILE EPILEPSY SYNDROME	0.01853655	0.6352702285890538
MOEBIUS SYNDROME; MBS	0.01848961	0.6336615374070393
HYPEREKPLEXIA 4; HKPX4	0.018479873	0.6333278385139999
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.018458133	0.6325827821378389
OCULOCEREBRORENAL SYNDROME OF LOWE	0.018416389	0.6311521642276979
19P13.3 MICRODUPLICATION SYNDROME	0.018402144	0.6306639706638336
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.018300879000000003	0.6271934953219782
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018259943	0.6257905685595805
WRINKLY SKIN SYNDROME	0.018118403999999998	0.6209398540045923
WIEACKER-WOLFF SYNDROME	0.018075373	0.6194651290311526
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01801618	0.617436512560403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017921153999999998	0.6141798553754412
RIN2 SYNDROME	0.01783647	0.611277631173104
MACS SYNDROME	0.01783647	0.611277631173104
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.017725613	0.607478426265465
2P15P16.1 MICRODELETION SYNDROME	0.017644754000000002	0.6047072894890162
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.017595304000000003	0.6030125775386409
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.017565834	0.6020026046129066
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.017564923	0.6019713835292505
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.017558934000000002	0.6017661331779705
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.017554799000000003	0.6016244216731211
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.01740343	0.5964368210014052
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01738044	0.5956489255971761
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017263314	0.5916348743959697
HYPERPROLINEMIA, TYPE I	0.017254172999999998	0.591321601151513
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.5908838548271017
ERYTHERMALGIA, PRIMARY	0.0172414	0.5908838548271017
DIASTEMATOMYELIA	0.0172414	0.5908838548271017
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.5908838548271017
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.5908838548271017
269800 SENILE PLAQUE FORMATION	0.0172414	0.5908838548271017
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.5908838548271017
THUMBS, CONGENITAL CLASPED	0.0172414	0.5908838548271017
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.5908838548271017
PALMOMENTAL REFLEX	0.0172414	0.5908838548271017
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.5908838548271017
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.5908838548271017
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.5908838548271017
ALCOHOL DEPENDENCE	0.0172414	0.5908838548271017
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.5908838548271017
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.5908838548271017
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.5908838548271017
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.5908838548271017
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.5908838548271017
JUMPING FRENCHMAN OF MAINE	0.0172414	0.5908838548271017
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.5908838548271017
MYOPATHY, CONGENITAL	0.0172414	0.5908838548271017
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.5908838548271017
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.5908838548271017
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.5908838548271017
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.5908838548271017
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.5908838548271017
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.5908838548271017
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.5908838548271017
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.5908838548271017
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.5908838548271017
SICKLE CELL ANEMIA	0.0172414	0.5908838548271017
MOSAIC TRISOMY 15	0.0172414	0.5908838548271017
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.5908838548271017
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.5908838548271017
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.5908838548271017
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.5908838548271017
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.5908838548271017
CERVICAL RIB	0.0172414	0.5908838548271017
TRANSSEXUALITY	0.0172414	0.5908838548271017
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.5908838548271017
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.5908838548271017
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.5908838548271017
CARDIAC ARRHYTHMIA	0.0172414	0.5908838548271017
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.5908838548271017
MOTION SICKNESS	0.0172414	0.5908838548271017
RHEUMATOID ARTHRITIS	0.0172414	0.5908838548271017
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.5908838548271017
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.5908838548271017
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.5908838548271017
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.5908838548271017
VASCULAR EHLERS-DANLOS SYNDROME	0.017230494	0.5905100928750128
RAPID-ONSET DYSTONIA-PARKINSONISM	0.017180059	0.5887816237705199
SHUKLA-VERNON SYNDROME; SHUVER	0.017177723	0.5887015661948661
MICROHYDRANENCEPHALY; MHAC	0.017170289999999998	0.5884468281983617
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.01714688	0.5876445388807019
MYHRE SYNDROME	0.017116413	0.5866003975461805
SPINOCEREBELLAR ATAXIA TYPE 12	0.01710526	0.5862181706021454
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.01710526	0.5862181706021454
22Q11.2 DELETION SYNDROME	0.017041192999999996	0.5840225161931525
MUCOPOLYSACCHARIDOSIS TYPE 2	0.017033853	0.5837709654203366
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.017028923	0.583602008293636
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.017017944	0.5832257445423078
FOUNTAIN SYNDROME	0.016972239	0.5816593783200247
CRANIOFACIAL DYSSYNOSTOSIS	0.016971760000000002	0.5816429624044691
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01694698	0.5807937215120464
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016830654	0.5768070872888036
COFFIN-LOWRY SYNDROME	0.016772499000000003	0.574814044346962
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.016754474	0.5741963055622193
LATHOSTEROLOSIS	0.016722549	0.5731021967853593
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.016712754	0.5727665101614174
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5727665101614174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.016712754	0.5727665101614174
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.01670285	0.572427087974228
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.01670263	0.5724195483052881
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01668494	0.5718132903800678
20P13 MICRODELETION SYNDROME	0.016629819	0.5699242263271531
SMITH-LEMLI-OPITZ SYNDROME	0.016614583000000002	0.5694020699818363
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.016597094	0.5688027005723294
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.016594884	0.568726961170705
FRANK-TER HAAR SYNDROME; FTHS	0.01656943	0.567854621474348
ASPARTYLGLUCOSAMINURIA	0.016488299	0.5650741629253916
ZIMMERMANN-LABAND SYNDROME 1	0.016488299	0.5650741629253916
JOUBERT SYNDROME 14	0.016487504	0.5650469173035402
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.016483369	0.5649052057986909
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0164686	0.5643990541142603
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.016364424000000002	0.5608288152438399
CARTILAGE-HAIR HYPOPLASIA	0.01634628	0.5602069981836253
SOTOS SYNDROME	0.016336853000000002	0.5598839233695467
MARSHALL-SMITH SYNDROME; MRSHSS	0.01633518	0.5598265876143802
GAUCHER DISEASE	0.016301509999999998	0.558672675554337
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.558672675554337
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.5583924740395491
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.016208794	0.5554951848932451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.016171013	0.5542003838376915
ROIFMAN-CHITAYAT SYNDROME	0.016042953999999998	0.5498116453613899
MOEBIUS SYNDROME	0.016033389999999998	0.5494838753898351
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.016031419999999998	0.5494163610815997
CATEL-MANZKE SYNDROME; CATMANS	0.015999683	0.5483286952945612
WILLIAMS SYNDROME	0.01594688	0.5465190719352959
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01594688	0.5465190719352959
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01578531	0.5409818705233216
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.015759873	0.5401101134377463
NON-DISTAL MONOSOMY 20Q	0.015749749	0.5397631515816169
NEMALINE MYOPATHY 7; NEM7	0.015643380000000002	0.5361177559203537
SCHWARTZ-JAMPEL SYNDROME	0.015632809999999997	0.5357555090990095
SMITH-KINGSMORE SYNDROME; SKS	0.015548539	0.532867438911546
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5302085061174131
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5302085061174131
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5302085061174131
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5302085061174131
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5302085061174131
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.5302085061174131
RABSON-MENDENHALL SYNDROME	0.015462624000000001	0.5299230268343672
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.015458489	0.5297813153295178
XQ28 (MECP2) DUPLICATION	0.015372673	0.526840296103362
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.015372673	0.526840296103362
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015364374	0.5265558792282121
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.015360473	0.526422187189417
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01531211	0.5247647280578498
KOOLEN-DE VRIES SYNDROME; KDVS	0.015223873	0.5217407382021316
BAKER-GORDON SYNDROME; BAGOS	0.015218454	0.5215550224476507
COFFIN-SIRIS SYNDROME 1; CSS1	0.015102033	0.5175651324582748
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.015100793	0.5175226361424312
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.015087123000000001	0.5170541485314781
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.015087123000000001	0.5170541485314781
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.015078888999999998	0.5167719592857877
ACROCRANIOFACIAL DYSOSTOSIS	0.01494989	0.5123510058603791
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5115117036224682
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5115117036224682
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5115117036224682
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.014923058999999999	0.5114314746907022
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0148978	0.5105658178827238
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0148978	0.5105658178827238
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0148978	0.5105658178827238
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0148978	0.5105658178827238
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.014882909	0.5100554851091539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.014856663	0.509156002604613
HOLMES-GANG SYNDROME	0.014831254	0.5082852051132664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.014831254	0.5082852051132664
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.5082852051132664
TURNPENNY-FRY SYNDROME; TPFS	0.014831254	0.5082852051132664
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.014827119	0.508143493608417
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01476438	0.5059933513828438
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.014742553999999998	0.5052453476815518
WIEDEMANN-STEINER SYNDROME	0.014701159	0.5038266904280475
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.014688442999999999	0.503390897563316
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.014652278999999999	0.5021515130744714
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.014565403	0.49917416635251377
20Q11.2 MICRODUPLICATION SYNDROME	0.014565403	0.49917416635251377
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.014545704	0.4984990575413825
OGDEN SYNDROME	0.014545704	0.4984990575413825
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014541569	0.49835734603653314
ARGININEMIA	0.014531803	0.4980226532780424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.014531803	0.4980226532780424
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.014529764	0.4979527742554577
HURLER SYNDROME	0.014527794	0.4978852599472223
MONOSOMY 18Q	0.014523293	0.4977310051749546
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014477714	0.49616895712670067
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.01441446	0.4940011652215635
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.014408899999999999	0.49381061722471636
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.014399784	0.4934982007608212
COFFIN-SIRIS SYNDROME 7; CSS7	0.014399784	0.4934982007608212
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014311109	0.4904592001096679
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.0142857	0.4895884026183214
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.4895884026183214
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.4895884026183214
INFANT BOTULISM	0.0142857	0.4895884026183214
CHILDHOOD APRAXIA OF SPEECH	0.0142857	0.4895884026183214
ALLAN-HERNDON-DUDLEY SYNDROME	0.0142857	0.4895884026183214
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0142857	0.4895884026183214
WILSON DISEASE	0.0142857	0.4895884026183214
NEUROLEPTIC MALIGNANT SYNDROME	0.0142857	0.4895884026183214
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.014268114	0.48898570890023646
FOCAL DERMAL HYPOPLASIA; FDH	0.01425919	0.4886798725110525
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.4881645704102265
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.4881645704102265
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.014142888999999999	0.4846940950683711
RAINE SYNDROME	0.014108524	0.48351636450872204
HALLERMANN-STREIFF SYNDROME; HSS	0.01405563	0.4817036224682134
FONTAINE PROGEROID SYNDROME; FPS	0.014015060000000001	0.48031323897323425
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014004494	0.47995112923677985
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.47995112923677985
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.014000150000000001	0.47980225504643753
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.013989699	0.47944408650056547
NEUROCUTANEOUS MELANOCYTOSIS	0.013986249	0.4793258507830974
ANGELMAN SYNDROME	0.013986249	0.4793258507830974
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.013986249	0.4793258507830974
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01398224	0.4791884574522774
NANCE-HORAN SYNDROME	0.013980260000000001	0.4791206004318174
KEIPERT SYNDROME	0.013980260000000001	0.4791206004318174
CARNOSINASE DEFICIENCY	0.013932159999999999	0.47747215463175574
RING CHROMOSOME 14 SYNDROME	0.013844903999999998	0.4744817848452654
LISSENCEPHALY 8; LIS8	0.013789672999999999	0.47258895095788067
PITT-HOPKINS SYNDROME	0.013787569	0.47251684430583635
15Q26 OVERGROWTH SYNDROME	0.013755380000000001	0.4714136879262484
PHELAN-MCDERMID SYNDROME	0.013737883	0.47081404434696184
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01372256	0.4702889064052915
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.4694677679152815
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.4694677679152815
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.4694677679152815
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.4694677679152815
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.4694677679152815
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.013660819000000001	0.4681729668597279
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013628593000000001	0.46706854244490903
MENKES DISEASE	0.013586849	0.46563792453476816
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.013468313	0.46157555090990104
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013439913	0.460602248192193
MONOSOMY 18P	0.013331304	0.4568800849926317
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.013328354	0.4567789848863909
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013307183	0.4560534288358066
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.013307183	0.4560534288358066
DESMOSTEROLOSIS	0.01329935	0.4557849823503204
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.013296983	0.45570386236677063
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.013282073	0.45519287843997397
MENTAL RETARDATION, X-LINKED 9	0.013282073	0.45519287843997397
INFANTILE LIVER FAILURE SYNDROME 1	0.013282073	0.45519287843997397
KRABBE DISEASE	0.013253094	0.45419973268446484
SCARF SYNDROME	0.01325152	0.45414578978032144
LAMB-SHAFFER SYNDROME	0.013243814000000001	0.45388169574008713
GERMAN SYNDROME	0.013243814000000001	0.45388169574008713
KLEEFSTRA SYNDROME	0.013229808999999999	0.4534017272696117
1P36 DELETION SYNDROME	0.013221973	0.45313317797045816
WILLIAMS-BEUREN SYNDROME; WBS	0.01320207	0.4524510778299462
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013051613	0.44729473251310875
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013051613	0.44729473251310875
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013051613	0.44729473251310875
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.013051613	0.44729473251310875
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013048932999999999	0.44720288563693067
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.012992150000000001	0.44525686281229654
ACRODYSOSTOSIS	0.01294239	0.44355152678296034
PFEIFFER SYNDROME	0.01294239	0.44355152678296034
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.012892023	0.44182538812159433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.012892023	0.44182538812159433
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012892023	0.44182538812159433
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.012880049	0.441415024503924
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012844893	0.44021018540731344
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01284347	0.44016141745776066
6Q25 MICRODELETION SYNDROME	0.012793173	0.4384376777819665
AL KAISSI SYNDROME; ALKAS	0.012793173	0.4384376777819665
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01278575	0.4381832824976867
PELIZAEUS-MERZBACHER DISEASE	0.012761629	0.4373566263408616
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.012761629	0.4373566263408616
FAMILIAL DYSAUTONOMIA	0.012761629	0.4373566263408616
METACHROMATIC LEUKODYSTROPHY	0.012761629	0.4373566263408616
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012761629	0.4373566263408616
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.012755564	0.437148771376675
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.012740654	0.43663778744987836
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.43663778744987836
GALACTOSE EPIMERASE DEFICIENCY	0.012740654	0.43663778744987836
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.43663778744987836
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.012740654	0.43663778744987836
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.012740654	0.43663778744987836
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.012736519	0.4364960759450289
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.012736519	0.4364960759450289
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.012736519	0.4364960759450289
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.012736519	0.4364960759450289
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.012736519	0.4364960759450289
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.012736519	0.4364960759450289
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.012736519	0.4364960759450289
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.012736519	0.4364960759450289
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.4364960759450289
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.012736519	0.4364960759450289
DILATED CARDIOMYOPATHY WITH ATAXIA	0.012736519	0.4364960759450289
GAUCHER DISEASE TYPE 3	0.01270754	0.43550293018951985
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0127027	0.43533705747284007
KNIEST-LIKE DYSPLASIA, LETHAL	0.01268839	0.43484663627951614
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.012609410000000001	0.43213989513005935
LATHOSTEROLOSIS	0.012600763	0.43184355186949513
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4311756057438569
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012561603000000001	0.4305014907981768
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.012510194	0.42873964152301314
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012506059	0.42859793001816376
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.012495884	0.4282492203296892
PRIMARY DYSTONIA, DYT4 TYPE	0.01237685	0.4241697796360396
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.4233503547071524
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.012350604000000001	0.4232702971314987
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012350604000000001	0.4232702971314987
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.012323029	0.42232526817231564
GENITOPATELLAR SYNDROME; GTPTS	0.012310814	0.42190664519003396
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.012299339	0.4215133829123685
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.012260704	0.4201893142328387
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.418801535350766
NEUROFERRITINOPATHY	0.01222021	0.418801535350766
CORTICOBASAL SYNDROME	0.01222021	0.418801535350766
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01222021	0.418801535350766
ADULT POLYGLUCOSAN BODY DISEASE	0.01222021	0.418801535350766
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.418801535350766
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.418801535350766
RHEUMATIC FEVER	0.01222021	0.418801535350766
HENNEKAM SYNDROME	0.012214799	0.4186160937660647
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.41794098495493337
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0121951	0.41794098495493337
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.0121951	0.41794098495493337
CLASSIC MULTIMINICORE MYOPATHY	0.0121951	0.41794098495493337
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.0121951	0.41794098495493337
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0121951	0.41794098495493337
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0121951	0.41794098495493337
RAMOS-ARROYO SYNDROME	0.0121951	0.41794098495493337
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0121951	0.41794098495493337
JOUBERT SYNDROME 4	0.0121951	0.41794098495493337
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0121951	0.41794098495493337
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0121951	0.41794098495493337
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0121951	0.41794098495493337
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0121951	0.41794098495493337
MEIER-GORLIN SYNDROME 3; MGORS3	0.01206902	0.4136200692278693
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.4126205147537612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4126205147537612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4126205147537612
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.4126205147537612
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4126205147537612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4126205147537612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.4126205147537612
FUMARASE DEFICIENCY; FMRD	0.012039854	0.4126205147537612
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4126205147537612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4126205147537612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4126205147537612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.4126205147537612
COHEN-GIBSON SYNDROME; COGIS	0.012037024	0.4125235271942151
1Q41Q42 MICRODELETION SYNDROME	0.012016049000000001	0.41180468830323186
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011980183	0.41057551663867853
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.40955241783474416
COCKAYNE SYNDROME A; CSA	0.011926209	0.4087257616779191
GAPO SYNDROME; GAPOS	0.011840758999999998	0.4057972857191815
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.011822929	0.4051862298228178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011820593	0.40510617224716405
GABRIELE-DE VRIES SYNDROME	0.011805050000000001	0.4045734946365538
OROFACIODIGITAL SYNDROME TYPE 6	0.011792763	0.4041524041262552
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011773243	0.4034834298639432
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011769454	0.4033535762020632
BENT BONE DYSPLASIA SYNDROME; BBDS	0.01175792	0.40295829192227284
FGFR2-RELATED BENT BONE DYSPLASIA	0.01175792	0.40295829192227284
INFANTILE SYSTEMIC HYALINOSIS	0.01175792	0.40295829192227284
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01171515	0.40149251173789374
MOSAIC TRISOMY 1	0.0117062	0.40118578429692586
CRI-DU-CHAT SYNDROME	0.0117062	0.40118578429692586
CHROMOSOME 18Q DELETION SYNDROME	0.011675609	0.40013739333082016
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01167338	0.400061002775969
SNEDDON SYNDROME	0.011666289	0.39981798553754416
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011663953000000001	0.3997379279618904
TRISOMY 20P	0.01157601	0.3967240138455739
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011513790000000001	0.39459165838445465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.3942449364268824
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.3942449364268824
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.3942449364268824
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.011503673	0.3942449364268824
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.011503673	0.3942449364268824
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011503673	0.3942449364268824
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.011503673	0.3942449364268824
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.011503673	0.3942449364268824
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.3942449364268824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.3942449364268824
6Q TERMINAL DELETION SYNDROME	0.011503673	0.3942449364268824
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.3939237122588163
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.3939237122588163
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.3939237122588163
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.3939237122588163
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.3939237122588163
MOWAT-WILSON SYNDROME	0.011434629	0.3918787141437335
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.3895494705096131
RING CHROMOSOME 7 SYNDROME	0.01133096	0.3883258507830974
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.011292869	0.3870204256485829
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01128151	0.38663113883272215
AU-KLINE SYNDROME; AUKS	0.011279174000000001	0.3865510812570685
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.011277989	0.3865104698584599
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.011275039	0.38640936975221907
COFFIN-LOWRY SYNDROME; CLS	0.011275039	0.38640936975221907
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.011227688999999999	0.3847866273689982
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011225352999999999	0.3847065697933445
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.38465677370711815
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.3833155351451386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.3833155351451386
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.011180629000000001	0.3831738236402893
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01112487	0.38126289454744855
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.011086973	0.3799641180300901
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.011086973	0.3799641180300901
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011086973	0.3799641180300901
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.011086973	0.3799641180300901
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011086973	0.3799641180300901
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.3794736968367662
GIANT AXONAL NEUROPATHY	0.011036029999999999	0.37821823914459024
14Q24.1Q24.3 MICRODELETION SYNDROME	0.011027200000000001	0.37791562425031705
3Q29 MICRODELETION SYNDROME	0.011007214000000001	0.37723067959834133
HEART AND BRAIN MALFORMATION SYNDROME	0.010988123	0.37657640769046236
SHORT RIB-POLYDACTYLY SYNDROME	0.01097775	0.37622091229994176
KBG SYNDROME	0.010968203	0.37589372493916856
DEND SYNDROME	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.3755481339319374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.3755481339319374
SLC39A8-CDG	0.010958119	0.3755481339319374
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.3755481339319374
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.010958119	0.3755481339319374
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.010958119	0.3755481339319374
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.010958119	0.3755481339319374
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.3755481339319374
XYLOSIDASE DEFICIENCY	0.010958119	0.3755481339319374
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.3755481339319374
AL-RAQAD SYNDROME; ARS	0.010928064	0.3745181123410672
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010828533000000001	0.37110706329894794
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.010828533	0.3711070632989478
GLASS SYNDROME	0.010803053	0.3702338325508071
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010803053	0.3702338325508071
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010795713	0.36998228177799103
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010795713	0.36998228177799103
INFANTILE SIALIC ACID STORAGE DISEASE	0.010795713	0.36998228177799103
RECOMBINANT 8 SYNDROME	0.010795713	0.36998228177799103
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.010745889999999998	0.36827478666164015
PROTEUS SYNDROME	0.010733620000000001	0.3678542787621235
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.01068627	0.36623153637890266
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.36623153637890266
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.36623153637890266
DYSTONIA 16	0.01068627	0.36623153637890266
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.01068627	0.36623153637890266
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.01068627	0.36623153637890266
AASE-SMITH SYNDROME	0.01063921	0.3646187326501936
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.3646187326501936
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01063921	0.3646187326501936
HYDROLETHALUS SYNDROME 1	0.01063921	0.3646187326501936
CRANIOFRONTONASAL SYNDROME; CFNS	0.010637924	0.36457465985811716
AARSKOG-SCOTT SYNDROME	0.010637924	0.36457465985811716
SIALIDOSIS TYPE 1	0.010627239	0.36420847184619076
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.010545554	0.36140902703999456
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010545554	0.36140902703999456
POPOV-CHANG SYNDROME; POPCHAS	0.010545554	0.36140902703999456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.010545554	0.36140902703999456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.36140902703999456
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.010545554	0.36140902703999456
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.010545554	0.36140902703999456
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010545554	0.36140902703999456
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.36091860584667057
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.010527109	0.36077689434182114
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.35952328729565786
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01049053	0.35952328729565786
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01049053	0.35952328729565786
CHROMOSOME 16Q22 DELETION SYNDROME	0.010446704000000001	0.35802131670036674
CHROMOSOME 9P DELETION SYNDROME	0.010446704000000001	0.35802131670036674
6Q16 MICRODELETION SYNDROME	0.010426784	0.357338633949073
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.010416700000000001	0.35699304294184175
OCULODENTODIGITAL DYSPLASIA	0.010312378999999998	0.35341783474416527
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01028945	0.35263202988450604
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01028945	0.35263202988450604
OTOPALATODIGITAL SYNDROME TYPE 2	0.010287114	0.35255197230885227
GABRIELE-DE VRIES SYNDROME; GADEVS	0.010287114	0.35255197230885227
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.010287114	0.35255197230885227
SECKEL SYNDROME 1; SCKL1	0.010282979000000001	0.35241026080400295
2Q32Q33 MICRODELETION SYNDROME	0.010261633999999999	0.35167874156071144
LIGNEOUS CONJUNCTIVITIS	0.010254294	0.3514271907878954
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.010254294	0.3514271907878954
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.010254294	0.3514271907878954
GM1 GANGLIOSIDOSIS	0.010250159	0.35128547928304604
C SYNDROME	0.010250159	0.35128547928304604
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.010250159	0.35128547928304604
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.010250159	0.35128547928304604
STURGE-WEBER SYNDROME	0.010250159	0.35128547928304604
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010149533	0.34783690325233907
ACROOSTEOLYSIS DOMINANT TYPE	0.01009237	0.34587785736317217
8P23.1 MICRODELETION SYNDROME	0.010064993	0.3449396141060352
FILIPPI SYNDROME	0.010064993	0.3449396141060352
15Q24 MICRODELETION SYNDROME	0.010064993	0.3449396141060352
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010033372999999998	0.3438559580520237
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010015543	0.3432449021556599
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010015543	0.3432449021556599
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.010015543	0.3432449021556599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.010015543	0.3432449021556599
PRADER-WILLI-LIKE SYNDROME	0.010015543	0.3432449021556599
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010015543	0.3432449021556599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.010015543	0.3432449021556599
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010015543	0.3432449021556599
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01	0.3427122245450495
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.01	0.3427122245450495
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.01	0.3427122245450495
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.01	0.3427122245450495
BETHLEM MYOPATHY 2; BTHLM2	0.01	0.3427122245450495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.3427122245450495
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.01	0.3427122245450495
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.3427122245450495
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.01	0.3427122245450495
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01	0.3427122245450495
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.3427122245450495
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.01	0.3427122245450495
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.01	0.3427122245450495
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01	0.3427122245450495
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.01	0.3427122245450495
KEIPERT SYNDROME; KPTS	0.00998569	0.3422218033517256
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00998569	0.3422218033517256
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00998569	0.3422218033517256
PELVISCAPULAR DYSPLASIA	0.00998569	0.3422218033517256
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00998569	0.3422218033517256
BARBER-SAY SYNDROME	0.009901150000000001	0.33932451420542176
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.33932451420542176
TRISOMY 18P	0.009901150000000001	0.33932451420542176
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.33932451420542176
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.33932451420542176
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.009901150000000001	0.33932451420542176
TETRASOMY 9P	0.009868222999999999	0.3381960656636622
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.3378766578703863
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.3378766578703863
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009858903	0.3378766578703863
INFANTILE REFSUM DISEASE	0.009858903	0.3378766578703863
MENTAL RETARDATION, X-LINKED 90	0.009858903	0.3378766578703863
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3360229617190445
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3360229617190445
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3360229617190445
BIOTINIDASE DEFICIENCY	0.009804814	0.3360229617190445
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3360229617190445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3360229617190445
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3358812502141951
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3358812502141951
JOUBERT SYNDROME WITH RENAL DEFECT	0.009743582999999998	0.3339245004969327
JOUBERT SYNDROME WITH OCULAR DEFECT	0.009743582999999998	0.3339245004969327
JOUBERT SYNDROME	0.009743582999999998	0.3339245004969327
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009743582999999998	0.3339245004969327
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.009741560000000002	0.33385516981390734
MAXILLOFACIAL DYSOSTOSIS	0.009741560000000002	0.33385516981390734
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009741560000000002	0.33385516981390734
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009716079999999998	0.3329819390657664
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.009716079999999998	0.3329819390657664
OTODENTAL SYNDROME	0.00970874	0.33273038829295043
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00970874	0.33273038829295043
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.33273038829295043
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.33273038829295043
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.33273038829295043
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00970874	0.33273038829295043
H SYNDROME	0.00970874	0.33273038829295043
ACUTE PROMYELOCYTIC LEUKEMIA	0.00970874	0.33273038829295043
ENAMEL-RENAL SYNDROME	0.00970874	0.33273038829295043
HEREDITARY GINGIVAL FIBROMATOSIS	0.00970874	0.33273038829295043
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00970874	0.33273038829295043
HYPOPLASMINOGENEMIA	0.00970874	0.33273038829295043
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00970874	0.33273038829295043
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00970874	0.33273038829295043
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.33273038829295043
JUVENILE HYALINE FIBROMATOSIS	0.00970874	0.33273038829295043
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.33273038829295043
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00970874	0.33273038829295043
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00970874	0.33273038829295043
OROFACIODIGITAL SYNDROME TYPE 2	0.009552444	0.3273739333082011
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00952683	0.3264961102162514
GOLDBERG-SHPRINTZEN SYNDROME	0.009523574	0.3263845231159396
FAMILIAL VISCERAL MYOPATHY	0.00948183	0.3249539052057987
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009474124	0.3246898111655643
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.009474124	0.3246898111655643
MENTAL RETARDATION, X-LINKED 106; MRX106	0.009474124	0.3246898111655643
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009474124	0.3246898111655643
2Q23.1 MICRODELETION SYNDROME	0.009469989	0.3245480996607149
5Q14.3 MICRODELETION SYNDROME	0.009469989	0.3245480996607149
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.009469989	0.3245480996607149
MENTAL RETARDATION, X-LINKED 21	0.009469989	0.3245480996607149
GAUCHER DISEASE, PERINATAL LETHAL	0.009469989	0.3245480996607149
POSTENCEPHALITIC PARKINSONISM	0.009469989	0.3245480996607149
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.009420303	0.3228452997018404
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.009420303	0.3228452997018404
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.009420303	0.3228452997018404
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.009420303	0.3228452997018404
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009420303	0.3228452997018404
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009420303	0.3228452997018404
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009420303	0.3228452997018404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.009420303	0.3228452997018404
N-ACETYLASPARTATE DEFICIENCY; NACED	0.009420303	0.3228452997018404
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009420303	0.3228452997018404
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00939519	0.3219846464923404
W SYNDROME	0.009392854	0.3219045889166867
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.009366749	0.32100993865451183
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00932914	0.3197210322492203
DE BARSY SYNDROME	0.009326804	0.31964097467356656
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.3193215668802906
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.3193215668802906
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.3193215668802906
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.3193215668802906
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.31917985537544125
SCLERODERMA	0.009313349	0.31917985537544125
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.31917985537544125
2Q33.1 DELETION SYNDROME	0.009313349	0.31917985537544125
CORNELIA DE LANGE SYNDROME 1	0.009313349	0.31917985537544125
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.31917985537544125
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.31917985537544125
PINEOBLASTOMA	0.009313349	0.31917985537544125
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.31917985537544125
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.31917985537544125
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.31917985537544125
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.31917985537544125
GAUCHER DISEASE TYPE 2	0.00925926	0.31732615922409957
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.31732615922409957
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.31732615922409957
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.31732615922409957
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.31732615922409957
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.31732615922409957
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.31732615922409957
HYDROXYLYSINURIA	0.00925926	0.31732615922409957
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.31732615922409957
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.31732615922409957
CARNOSINEMIA	0.00925926	0.31732615922409957
PAINE SYNDROME	0.00925926	0.31732615922409957
608028 THAI SYMPHALANGISM SYNDROME	0.00922215	0.31605435415881283
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.009222149999999998	0.31605435415881283
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.009208153	0.31557465985811717
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.009208153	0.31557465985811717
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.009202164	0.3153694095068371
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.009198029	0.31522769800198774
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.009130162999999998	0.31290184721889025
DISTAL TRISOMY 5Q	0.00906256	0.3105850097672984
CARPENTER SYNDROME	0.00902538	0.3093108057164399
DESANTO-SHINAWI SYNDROME	0.009023483	0.3092457932074437
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.009023483	0.3092457932074437
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009023483	0.3092457932074437
GENITOPATELLAR SYNDROME	0.008998003000000001	0.30837256245930295
ZLOTOGORA-OGUR SYNDROME	0.008984009000000001	0.3078929709722746
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00892857	0.3059930086706193
MONOSOMY 22	0.00892857	0.3059930086706193
ALLAN-HERNDON-DUDLEY SYNDROME	0.00892857	0.3059930086706193
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00892857	0.3059930086706193
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.008878884	0.3042902087117447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.008878884	0.3042902087117447
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.008878884	0.3042902087117447
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.008878884	0.3042902087117447
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.008878884	0.3042902087117447
PEROXISOME BIOGENESIS DISORDER 5B	0.008878884	0.3042902087117447
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.008878884	0.3042902087117447
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.008878884	0.3042902087117447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.008878884	0.3042902087117447
CEREBELLOPARENCHYMAL DISORDER II	0.008874749	0.30414849720689535
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.008874749	0.30414849720689535
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008874749	0.30414849720689535
INCONTINENTIA PIGMENTI	0.008808752999999999	0.30188673360978785
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.3006247643853457
MILROY DISEASE	0.00877193	0.3006247643853457
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.3006247643853457
HISTIDINEMIA	0.00877193	0.3006247643853457
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.3006247643853457
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.3006247643853457
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.3006247643853457
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.3006247643853457
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.3006247643853457
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.3006247643853457
HISTIDINEMIA	0.00877193	0.3006247643853457
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.3006247643853457
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00877193	0.3006247643853457
CAFFEY DISEASE	0.00877193	0.3006247643853457
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.3006247643853457
BREATH-HOLDING SPELLS	0.00877193	0.3006247643853457
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.3006247643853457
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.3006247643853457
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.3006247643853457
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.3006247643853457
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008662599	0.2968778573631722
CADASIL	0.008662599	0.2968778573631722
PARTINGTON SYNDROME	0.008662599	0.2968778573631722
MUSCLE-EYE-BRAIN DISEASE	0.008662599	0.2968778573631722
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.008662599	0.2968778573631722
ALEXANDER DISEASE	0.008662599	0.2968778573631722
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008648243	0.29638585969361525
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00859108	0.29442681380444835
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008588743999999999	0.29434675622879464
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.008588743999999999	0.29434675622879464
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.008584608999999998	0.29420504472394526
MELNICK-NEEDLES SYNDROME	0.00850392	0.29143973405531376
BARTH SYNDROME; BTHS	0.00850392	0.29143973405531376
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.2906907022173481
FETAL HYDANTOIN SYNDROME	0.008482064000000001	0.2906907022173481
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.2906907022173481
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.008482064000000001	0.2906907022173481
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.008477929	0.29054899071249873
OCULODENTODIGITAL DYSPLASIA; ODDD	0.008477929	0.29054899071249873
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.008477929	0.29054899071249873
MECKEL SYNDROME, TYPE 10; MKS10	0.008477929	0.29054899071249873
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.29054899071249873
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.29054899071249873
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.008477929	0.29054899071249873
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.008452449	0.28967575996435796
MEIER-GORLIN SYNDROME 6; MGORS6	0.00843149	0.288957469412934
LATERAL MENINGOCELE SYNDROME	0.00843149	0.288957469412934
WOLCOTT-RALLISON SYNDROME	0.008391819	0.28759789574694133
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.008344483	0.28597563316083485
CORNELIA DE LANGE SYNDROME 3	0.008344483	0.28597563316083485
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.008344483	0.28597563316083485
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.00833333	0.28559340621679974
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00833333	0.28559340621679974
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00833333	0.28559340621679974
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.00833333	0.28559340621679974
SYRINGOMYELIA, ISOLATED	0.00833333	0.28559340621679974
SYDENHAM CHOREA	0.00833333	0.28559340621679974
ATAXIA-PANCYTOPENIA SYNDROME	0.00833333	0.28559340621679974
PLAGUE	0.00833333	0.28559340621679974
PROGRESSIVE SUPRANUCLEAR PALSY	0.00833333	0.28559340621679974
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.00833333	0.28559340621679974
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00833333	0.28559340621679974
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.00833333	0.28559340621679974
DEAFNESS, X-LINKED 5; DFNX5	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00833333	0.28559340621679974
KURU, SUSCEPTIBILITY TO	0.00833333	0.28559340621679974
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00833333	0.28559340621679974
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA TYPE 40	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00833333	0.28559340621679974
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.00833333	0.28559340621679974
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00833333	0.28559340621679974
MYXOPAPILLARY EPENDYMOMA	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA TYPE 6	0.00833333	0.28559340621679974
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00833333	0.28559340621679974
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00833333	0.28559340621679974
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA 42	0.00833333	0.28559340621679974
CHIARI MALFORMATION TYPE I	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA TYPE 43	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00833333	0.28559340621679974
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA TYPE 8	0.00833333	0.28559340621679974
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00833333	0.28559340621679974
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00833333	0.28559340621679974
HUNTINGTON DISEASE-LIKE 1	0.00833333	0.28559340621679974
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00833333	0.28559340621679974
VERVERI-BRADY SYNDROME; VERBRAS	0.00833333	0.28559340621679974
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.008287319999999999	0.28401658727166795
CRANIOFACIOFRONTODIGITAL SYNDROME	0.008287319999999999	0.28401658727166795
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.2831899311148428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008259943	0.283078344014531
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008259943	0.283078344014531
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.008259943	0.283078344014531
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.008259943	0.283078344014531
KOOLEN-DE VRIES SYNDROME	0.008259943	0.283078344014531
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008259943	0.283078344014531
MOSAIC TRISOMY 14	0.008259943	0.283078344014531
MESOMELIA-SYNOSTOSES SYNDROME	0.00812773	0.27854724288015353
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00812773	0.27854724288015353
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00812118	0.2783227663730765
MUCOLIPIDOSIS TYPE IV	0.00812118	0.2783227663730765
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008112813	0.2780360190547997
CEDNIK SYNDROME	0.008100353	0.27760899962301655
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.008100353	0.27760899962301655
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.008063173	0.27633479557215807
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.008063173	0.27633479557215807
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.008043189999999999	0.27564995373384965
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.008043189999999999	0.27564995373384965
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.008043189999999999	0.27564995373384965
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00793651	0.2719938997224032
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.2719938997224032
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.2719938997224032
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.2719938997224032
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.00793651	0.2719938997224032
BRANCHIOOTIC SYNDROME 2	0.00793651	0.2719938997224032
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.2719938997224032
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.2719938997224032
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00793651	0.2719938997224032
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.2719938997224032
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.2719938997224032
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.2719938997224032
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.2719938997224032
RESTRICTIVE DERMOPATHY, LETHAL	0.00793651	0.2719938997224032
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.2719938997224032
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.2719938997224032
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.2719938997224032
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.2719938997224032
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.2719938997224032
KENNERKNECHT SYNDROME	0.00793651	0.2719938997224032
184705 STEINFELD SYNDROME	0.00793651	0.2719938997224032
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00793651	0.2719938997224032
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.2719938997224032
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.2719938997224032
WOLFRAM-LIKE SYNDROME	0.00793651	0.2719938997224032
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.2719938997224032
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.2719938997224032
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.2719938997224032
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00793651	0.2719938997224032
MEHMO SYNDROME	0.007917019	0.2713259193255424
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00791103	0.2711206689742623
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00791103	0.2711206689742623
DUANE RETRACTION SYNDROME	0.007803492999999999	0.2674352445251722
PSEUDOAMINOPTERIN SYNDROME	0.007803063999999999	0.2674205421707392
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.007803063999999999	0.2674205421707392
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.007803063999999999	0.2674205421707392
SAETHRE-CHOTZEN SYNDROME	0.007798929	0.26727883066588987
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.007798929	0.26727883066588987
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0077245130000000006	0.2647285033757154
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.26463484012474725
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007721779999999999	0.26463484012474725
OSTEOGENESIS IMPERFECTA	0.007721779999999999	0.26463484012474725
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007721779999999999	0.26463484012474725
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.007718524	0.2645232530244354
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.007714389	0.26438154151958604
LISSENCEPHALY, X-LINKED, 2	0.007714389	0.26438154151958604
TEMTAMY SYNDROME; TEMTYS	0.007643903	0.2619659001336577
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2600433188251825
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2600433188251825
1Q44 MICRODELETION SYNDROME	0.007587804	0.2600433188251825
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2600433188251825
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2600433188251825
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2600433188251825
X SMALL RINGS	0.007587804	0.2600433188251825
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2600433188251825
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2599016073203331
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2599016073203331
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.007567259	0.2593392165598547
POTOCKI-LUPSKI SYNDROME	0.0075649229999999994	0.25925915898420093
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.007561699	0.25914866856300767
MONOSOMY 13Q34	0.007558934	0.25905390863292094
CHROMOSOME 17P13.1 DELETION SYNDROME	0.007558934	0.25905390863292094
HYPERTRICHOSIS CUBITI	0.007558934	0.25905390863292094
DISTAL TRISOMY 15Q	0.007554798999999999	0.25891219712807156
MULTIPLE METAPHYSEAL DYSPLASIA	0.0074621	0.25573528907776144
NON-DISTAL MONOSOMY 10Q	0.0074621	0.25573528907776144
PETERS-PLUS SYNDROME; PTRPLS	0.0074096529999999996	0.25393786627368997
2Q37 MICRODELETION SYNDROME	0.007409652999999999	0.2539378662736899
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007406244	0.2538210356763426
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.007406243999999999	0.25382103567634257
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.007402109	0.2536793241714932
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.007325112999999999	0.2510405771273861
MONOSOMY 22Q13.3	0.007325112999999999	0.2510405771273861
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007325112999999999	0.2510405771273861
CINCA SYNDROME	0.007267633999999999	0.24907070153192362
ADAMS-OLIVER SYNDROME	0.007263499	0.24892899002707425
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.007263499	0.24892899002707425
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.007263499	0.24892899002707425
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0072620739999999994	0.2488801535350766
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00725751	0.24872373967579423
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00725751	0.24872373967579423
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00725751	0.24872373967579423
URBAN-ROGERS-MEYER SYNDROME	0.00725751	0.24872373967579423
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.007237952999999999	0.24805349737825147
NEONATAL ADRENOLEUKODYSTROPHY	0.007178959	0.24603170088077042
ZELLWEGER SYNDROME	0.007178959	0.24603170088077042
ADULT SYNDROME	0.00717297	0.2458264505294904
WAARDENBURG-SHAH SYNDROME	0.00717297	0.2458264505294904
WAARDENBURG SYNDROME	0.00717297	0.2458264505294904
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00717297	0.2458264505294904
600736 VELOFACIOSKELETAL SYNDROME	0.00717297	0.2458264505294904
STROMME SYNDROME; STROMS	0.00717297	0.2458264505294904
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.007171993999999999	0.24579300181637476
MONOSOMY 9Q22.3	0.007165523	0.2455712327358717
DONNAI-BARROW SYNDROME	0.007165523	0.2455712327358717
DESBUQUOIS DYSPLASIA 1	0.0071048199999999995	0.24349086671921588
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.24134651633023751
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.24134651633023751
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.24134651633023751
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.24134651633023751
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.24134651633023751
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.24134651633023751
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.24134651633023751
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.24134651633023751
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.24134651633023751
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.24134651633023751
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.24134651633023751
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.24134651633023751
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.24134651633023751
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.24134651633023751
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.24134651633023751
OLIVER SYNDROME	0.00704225	0.24134651633023751
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.24134651633023751
AMISH LETHAL MICROCEPHALY	0.00704225	0.24134651633023751
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.24134651633023751
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.24134651633023751
17P11.2 MICRODUPLICATION SYNDROME	0.007023504	0.24070406799410535
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.007019369	0.24056235648925597
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.007019369	0.24056235648925597
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.007019369	0.24056235648925597
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.007013809	0.24037180849240894
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.007013809	0.24037180849240894
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00701338	0.24035710613797595
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00701338	0.24035710613797595
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00701338	0.24035710613797595
BARDET-BIEDL SYNDROME	0.00701338	0.24035710613797595
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00701338	0.24035710613797595
NEUROFACIODIGITORENAL SYNDROME	0.00701338	0.24035710613797595
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00701338	0.24035710613797595
SECKEL SYNDROME 5; SCKL5	0.00701338	0.24035710613797595
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00701338	0.24035710613797595
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00701338	0.24035710613797595
ISOLATED CLEFT LIP	0.006976199999999999	0.23908290208711744
LOEYS-DIETZ SYNDROME 3; LDS3	0.006976199999999999	0.23908290208711744
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.006976199999999999	0.23908290208711744
ACHONDROGENESIS TYPE 1B	0.006976199999999999	0.23908290208711744
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.006905843	0.23667168168888586
RUBINSTEIN-TAYBI SYNDROME	0.006905843	0.23667168168888586
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006888192999999999	0.23606679461256383
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006888192999999999	0.23606679461256383
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006868233999999999	0.23538277528359436
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.006868233999999999	0.23538277528359436
PETERS PLUS SYNDROME	0.006868233999999999	0.23538277528359436
ADAMS-OLIVER SYNDROME 5; AOS5	0.0068640989999999985	0.23524106377874493
ADNP SYNDROME	0.0068640989999999985	0.23524106377874493
NATIVE AMERICAN MYOPATHY	0.00686069	0.2351242331813976
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00686069	0.2351242331813976
LOEYS-DIETZ SYNDROME 5	0.00686069	0.2351242331813976
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.006783694	0.23248548613729053
PALLISTER-KILLIAN SYNDROME	0.006779558999999999	0.23234377463244113
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.006779558999999999	0.23234377463244113
COFFIN-SIRIS SYNDROME 6; CSS6	0.006752724	0.23142410637787453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.006748588999999999	0.2312823948730251
JOUBERT SYNDROME 24	0.0066965340000000005	0.22949840638815588
NOONAN SYNDROME 6; NS6	0.006668184000000001	0.2285268172315707
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006668184000000001	0.2285268172315707
15Q OVERGROWTH SYNDROME	0.006664049	0.22838510572672127
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00663754	0.22747660989067478
LATERAL MENINGOCELE SYNDROME	0.006624104	0.22701614174577608
BRANCHIOSKELETOGENITAL SYNDROME	0.006619969	0.22687443024092668
XP22.13P22.2 DUPLICATION SYNDROME	0.006619969	0.22687443024092668
CAREY-FINEMAN-ZITER SYNDROME	0.00655693	0.22471400664861715
PYRUVATE DEHYDROGENASE DEFICIENCY	0.006499893	0.22275927893347955
FREEMAN-SHELDON SYNDROME	0.00647239	0.22181671750231333
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00647239	0.22181671750231333
COG1-CDG	0.00647239	0.22181671750231333
BASAL CELL NEVUS SYNDROME	0.006366759999999999	0.2181966482744439
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.006366759999999999	0.2181966482744439
3C SYNDROME	0.0063644240000000005	0.21811659069879025
ELSAHY-WATERS SYNDROME; ESWS	0.0063644240000000005	0.21811659069879025
OROFACIODIGITAL SYNDROME TYPE 1	0.006360289	0.21797487919394087
POTOCKI-SHAFFER SYNDROME	0.006360289	0.21797487919394087
AYME-GRIPP SYNDROME; AYGRP	0.006360289	0.21797487919394087
OROFACIODIGITAL SYNDROME I; OFD1	0.006360289	0.21797487919394087
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.006342639000000001	0.21736999211761887
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.006295303	0.2157477295315124
MEND SYNDROME; MEND	0.006295303	0.2157477295315124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.006295303	0.2157477295315124
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.006295303	0.2157477295315124
MEND SYNDROME	0.006295303	0.2157477295315124
POTOCKI-SHAFFER SYNDROME	0.006295303	0.2157477295315124
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.006295303	0.2157477295315124
15Q14 MICRODELETION SYNDROME	0.006295303	0.2157477295315124
PMM2-CDG	0.006295303	0.2157477295315124
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006295303	0.2157477295315124
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006295303	0.2157477295315124
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.006295303	0.2157477295315124
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006295303	0.2157477295315124
CK SYNDROME	0.006295303	0.2157477295315124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.006295303	0.2157477295315124
FRASER SYNDROME	0.00623814	0.21378868364234552
9P13 MICRODELETION SYNDROME	0.00623814	0.21378868364234552
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00623814	0.21378868364234552
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00623814	0.21378868364234552
CLASSICAL EHLERS-DANLOS SYNDROME	0.00623814	0.21378868364234552
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00623814	0.21378868364234552
OMODYSPLASIA 1; OMOD1	0.00623814	0.21378868364234552
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00623814	0.21378868364234552
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00623814	0.21378868364234552
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00615098	0.21080160389321087
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00615098	0.21080160389321087
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00615098	0.21080160389321087
MIRAGE SYNDROME; MIRAGE	0.006142613	0.21051485657493405
NEONATAL MARFAN SYNDROME	0.00612263	0.2098300147366257
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.006078549999999999	0.20831933925083107
SCARF SYNDROME	0.006078549999999999	0.20831933925083107
SHPRINTZEN-GOLDBERG SYNDROME	0.006078549999999999	0.20831933925083107
ARTERIAL TORTUOSITY SYNDROME	0.006078549999999999	0.20831933925083107
CHARGE SYNDROME	0.006078549999999999	0.20831933925083107
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.0059543389999999995	0.20406247643853453
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.005838853	0.2001046300421536
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.2001046300421536
GENITOPALATOCARDIAC SYNDROME	0.00581887	0.19941978820384523
CRANIOFRONTONASAL DYSPLASIA	0.00581887	0.19941978820384523
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00581887	0.19941978820384523
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00581887	0.19941978820384523
ROBERTS SYNDROME; RBS	0.00581887	0.19941978820384523
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00580122	0.19881490112752323
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00580122	0.19881490112752323
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00580122	0.19881490112752323
BEHR SYNDROME	0.00580122	0.19881490112752323
MAST SYNDROME	0.00580122	0.19881490112752323
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00580122	0.19881490112752323
DYSTONIA 16; DYT16	0.00580122	0.19881490112752323
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00580122	0.19881490112752323
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00580122	0.19881490112752323
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.005794749	0.19859313204702014
TETRASOMY 18P	0.005794749	0.19859313204702014
HARTNUP DISEASE	0.0057598729999999996	0.1973978888926968
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.0057598729999999996	0.1973978888926968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0057598729999999996	0.1973978888926968
SCHIZENCEPHALY	0.0057598729999999996	0.1973978888926968
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0057598729999999996	0.1973978888926968
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0057598729999999996	0.1973978888926968
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0057598729999999996	0.1973978888926968
TAY-SACHS DISEASE	0.0057598729999999996	0.1973978888926968
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.0057598729999999996	0.1973978888926968
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0057598729999999996	0.1973978888926968
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0057598729999999996	0.1973978888926968
SEVERE CANAVAN DISEASE	0.0057598729999999996	0.1973978888926968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0057598729999999996	0.1973978888926968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0057598729999999996	0.1973978888926968
VICI SYNDROME	0.0057598729999999996	0.1973978888926968
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0057598729999999996	0.1973978888926968
GALLOWAY-MOWAT SYNDROME	0.0057598729999999996	0.1973978888926968
CANAVAN DISEASE	0.0057598729999999996	0.1973978888926968
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.0057598729999999996	0.1973978888926968
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.0057598729999999996	0.1973978888926968
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0057598729999999996	0.1973978888926968
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0057598729999999996	0.1973978888926968
CENTRAL BILATERAL MACROGYRIA	0.0057598729999999996	0.1973978888926968
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0057598729999999996	0.1973978888926968
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0057598729999999996	0.1973978888926968
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0057598729999999996	0.1973978888926968
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0057598729999999996	0.1973978888926968
TARP SYNDROME	0.0057543130000000005	0.19720734089584976
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0057543130000000005	0.19720734089584976
TETRASOMY 5P	0.0057543130000000005	0.19720734089584976
1Q21.1 MICRODELETION SYNDROME	0.0057543130000000005	0.19720734089584976
DISTAL TRISOMY 6P	0.005753884	0.19719263854141678
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005753884	0.19719263854141678
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005753884	0.19719263854141678
12Q14 MICRODELETION SYNDROME	0.005753884	0.19719263854141678
OCULOFACIOCARDIODENTAL SYNDROME	0.005753884	0.19719263854141678
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.005753884	0.19719263854141678
FRONTOOCULAR SYNDROME	0.005753884	0.19719263854141678
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.005753884	0.19719263854141678
ALAZAMI-YUAN SYNDROME	0.005753884	0.19719263854141678
FORSYTHE-WAKELING SYNDROME; FWS	0.005753884	0.19719263854141678
HADZISELIMOVIC SYNDROME	0.005753884	0.19719263854141678
DISTAL TRISOMY 18Q	0.005753884	0.19719263854141678
SAY-BARBER-MILLER SYNDROME	0.005753884	0.19719263854141678
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005749749	0.1970509270365674
SAUL-WILSON SYNDROME; SWILS	0.0056011939999999994	0.1919597655848384
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0056011939999999994	0.1919597655848384
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.005597059	0.19181805407998903
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00549746	0.1884046745947428
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00549746	0.1884046745947428
LERI PLEONOSTEOSIS	0.00549746	0.1884046745947428
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00541292	0.18550738544843895
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.1837099626443675
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.005360472999999999	0.1837099626443675
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.1837099626443675
IMMUNODEFICIENCY 49; IMD49	0.005360472999999999	0.1837099626443675
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.1837099626443675
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.1837099626443675
SIALIDOSIS TYPE 2	0.005360472999999999	0.1837099626443675
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0052533300000000005	0.1800380410569245
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.005244963	0.17975129373864765
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.005244963	0.17975129373864765
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.17884279790260119
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.005214319	0.1787010863977518
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.1787010863977518
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.1787010863977518
COCKAYNE SYNDROME	0.005214319	0.1787010863977518
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.1787010863977518
RETT SYNDROME	0.005214319	0.1787010863977518
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.005214319	0.1787010863977518
KRABBE DISEASE	0.005214319	0.1787010863977518
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.1787010863977518
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.005214319	0.1787010863977518
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.005214319	0.1787010863977518
CEREBROTENDINOUS XANTHOMATOSIS	0.005214319	0.1787010863977518
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.1787010863977518
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.1787010863977518
XERODERMA PIGMENTOSUM	0.005214319	0.1787010863977518
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.1787010863977518
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.1787010863977518
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.1787010863977518
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.1787010863977518
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.005214319	0.1787010863977518
DERMOTRICHIC SYNDROME	0.005214319	0.1787010863977518
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.1787010863977518
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.1787010863977518
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.1787010863977518
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005214319	0.1787010863977518
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.1787010863977518
MILLER-DIEKER SYNDROME	0.005214319	0.1787010863977518
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.1787010863977518
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.005214319	0.1787010863977518
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.1787010863977518
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.1787010863977518
BANGSTAD SYNDROME	0.005214319	0.1787010863977518
AUTISM	0.005214319	0.1787010863977518
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.1787010863977518
EPILEPSY, READING	0.005214319	0.1787010863977518
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.1787010863977518
KABUKI SYNDROME	0.005214319	0.1787010863977518
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.1787010863977518
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005214319	0.1787010863977518
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.1787010863977518
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.1787010863977518
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.005214319	0.1787010863977518
RETT SYNDROME; RTT	0.005214319	0.1787010863977518
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.1787010863977518
HUNTINGTON DISEASE-LIKE 1	0.005214319	0.1787010863977518
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.1787010863977518
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.005214319	0.1787010863977518
TARP SYNDROME; TARPS	0.005212894	0.17865224990575415
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.005212894	0.17865224990575415
CEREBROFACIOARTICULAR SYNDROME	0.005212894	0.17865224990575415
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.005208759	0.17851053840090478
MENTAL RETARDATION, X-LINKED 45	0.00520833	0.17849583604647176
%608572 BURN-MCKEOWN SYNDROME	0.00520833	0.17849583604647176
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00520833	0.17849583604647176
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00520833	0.17849583604647176
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00520833	0.17849583604647176
FRAXE INTELLECTUAL DISABILITY	0.00520833	0.17849583604647176
RUIJS-AALFS SYNDROME; RJALS	0.00520833	0.17849583604647176
NIJMEGEN BREAKAGE SYNDROME	0.00520833	0.17849583604647176
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00520833	0.17849583604647176
BALLER-GEROLD SYNDROME	0.00520833	0.17849583604647176
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00520833	0.17849583604647176
WOODHOUSE-SAKATI SYNDROME	0.00520833	0.17849583604647176
NANCE-HORAN SYNDROME	0.00520833	0.17849583604647176
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00520833	0.17849583604647176
FRYNS-SMEETS-THIRY SYNDROME	0.00520833	0.17849583604647176
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00520833	0.17849583604647176
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00520833	0.17849583604647176
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00520833	0.17849583604647176
CEREBROOCULONASAL SYNDROME	0.00520833	0.17849583604647176
WARBURG MICRO SYNDROME 2; WARBM2	0.00520833	0.17849583604647176
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.005100792999999999	0.17481041159738167
MATERNAL PHENYLKETONURIA	0.005100792999999999	0.17481041159738167
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00505564	0.17326296308989342
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00505564	0.17326296308989342
EHLERS-DANLOS SYNDROME, TYPE VI	0.00505564	0.17326296308989342
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00505564	0.17326296308989342
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00505564	0.17326296308989342
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00505564	0.17326296308989342
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00505564	0.17326296308989342
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00505564	0.17326296308989342
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00505564	0.17326296308989342
CENTRAL CORE DISEASE	0.00505564	0.17326296308989342
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00505564	0.17326296308989342
WEAVER SYNDROME	0.005053304	0.1731829055142397
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.005053304	0.1731829055142397
COSTELLO SYNDROME; CSTLO	0.005053304	0.1731829055142397
DISTAL MONOSOMY 6P	0.005053304	0.1731829055142397
20Q13.33 MICRODELETION SYNDROME	0.005049169	0.17304119400939033
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004943539	0.16942112478152097
RUVALCABA SYNDROME	0.004941203	0.16934106720586725
2Q31.1 MICRODELETION SYNDROME	0.004941203	0.16934106720586725
MUENKE SYNDROME	0.004941203	0.16934106720586725
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004941203	0.16934106720586725
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004863134	0.16666554714006648
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004858999	0.1665238356352171
COG5-CDG	0.004858999	0.1665238356352171
3Q29 MICRODUPLICATION SYNDROME	0.004856663000000001	0.1664437780595634
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004856663000000001	0.1664437780595634
ZTTK SYNDROME; ZTTKS	0.004856663000000001	0.1664437780595634
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004856663000000001	0.1664437780595634
HELSMOORTEL-VAN DER AA SYNDROME	0.004856663000000001	0.1664437780595634
JACOBSEN SYNDROME	0.004856663000000001	0.1664437780595634
MAN1B1-CDG	0.004856663000000001	0.1664437780595634
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004856663000000001	0.1664437780595634
CHROMOSOME 10Q26 DELETION SYNDROME	0.004856663000000001	0.1664437780595634
TOWNES-BROCKS SYNDROME 1; TBS1	0.004819054	0.16515487165427192
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004819054	0.16515487165427192
PERIPHERAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.16515487165427192
ABLEPHARON MACROSTOMIA SYNDROME	0.004819054	0.16515487165427192
ICF SYNDROME	0.004819054	0.16515487165427192
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004819054	0.16515487165427192
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.004819054	0.16515487165427192
THYROID HEMIAGENESIS	0.004819054	0.16515487165427192
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004819054	0.16515487165427192
FANCONI ANEMIA	0.004819054	0.16515487165427192
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004819054	0.16515487165427192
THYROID ECTOPIA	0.004819054	0.16515487165427192
FAMILIAL THYROID DYSHORMONOGENESIS	0.004819054	0.16515487165427192
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004819054	0.16515487165427192
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004819054	0.16515487165427192
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004819054	0.16515487165427192
CONGENITAL HYPOTHYROIDISM	0.004819054	0.16515487165427192
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.16501316014942252
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.004814918999999999	0.16501316014942252
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.004814918999999999	0.16501316014942252
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.16501316014942252
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.16501316014942252
DISTAL MONOSOMY 3P	0.004814918999999999	0.16501316014942252
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.16501316014942252
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00475188	0.162852736557113
ATELOSTEOGENESIS TYPE I	0.00475188	0.162852736557113
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00475188	0.162852736557113
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.162852736557113
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00475188	0.162852736557113
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00475188	0.162852736557113
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.162852736557113
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.162852736557113
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.162852736557113
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00475188	0.162852736557113
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.162852736557113
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.162852736557113
ATELOSTEOGENESIS, TYPE I; AO1	0.00475188	0.162852736557113
LETHAL KNIEST-LIKE DYSPLASIA	0.00475188	0.162852736557113
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0047035440000000005	0.16119620274855206
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004699409	0.16105449124370266
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.004699409	0.16105449124370266
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004699409	0.16105449124370266
CONGENITAL HYDROCEPHALUS	0.004699409	0.16105449124370266
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004699409	0.16105449124370266
SACCHAROPINURIA	0.0046729	0.16014599540765617
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.16014599540765617
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.16014599540765617
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.16014599540765617
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0046729	0.16014599540765617
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.16014599540765617
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.16014599540765617
ISAAC SYNDROME	0.0046729	0.16014599540765617
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.16014599540765617
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.16014599540765617
SCHIZOPHRENIA	0.0046729	0.16014599540765617
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.16014599540765617
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.16014599540765617
ARGININOSUCCINIC ACIDURIA	0.0046729	0.16014599540765617
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00466734	0.15995544741080914
TEEBI-SHALTOUT SYNDROME; TBSH	0.00466734	0.15995544741080914
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00466734	0.15995544741080914
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00466734	0.15995544741080914
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00466734	0.15995544741080914
TRISOMY 8Q	0.004559374	0.15625532060728606
FLOATING-HARBOR SYNDROME	0.004559374	0.15625532060728606
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555238999999999	0.15611360910243666
HALL-RIGGS SYNDROME	0.004555238999999999	0.15611360910243666
L1 SYNDROME	0.004535253	0.15542866445046097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.15542866445046097
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004535253	0.15542866445046097
NIEMANN-PICK DISEASE TYPE C	0.004535253	0.15542866445046097
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.15542866445046097
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.15542866445046097
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.15542866445046097
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.15542866445046097
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0045352529999999995	0.15542866445046094
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0045352529999999995	0.15542866445046094
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0045352529999999995	0.15542866445046094
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0045352529999999995	0.15542866445046094
FREE SIALIC ACID STORAGE DISEASE	0.0045352529999999995	0.15542866445046094
16P13.2 MICRODELETION SYNDROME	0.0045352529999999995	0.15542866445046094
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0045352529999999995	0.15542866445046094
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00450775	0.1544861030192947
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00450775	0.1544861030192947
MARTSOLF SYNDROME	0.00450775	0.1544861030192947
ODONTOCHONDRODYSPLASIA; ODCD	0.00440212	0.15086603379142535
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00440212	0.15086603379142535
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00440212	0.15086603379142535
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00440212	0.15086603379142535
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00440212	0.15086603379142535
CHST3-RELATED SKELETAL DYSPLASIA	0.00440212	0.15086603379142535
LARON SYNDROME	0.00440212	0.15086603379142535
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.004399784	0.15078597621577164
TRISOMY 9P	0.004399784	0.15078597621577164
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.004399784	0.15078597621577164
%300712 CRANIOFACIOSKELETAL SYNDROME	0.004399784	0.15078597621577164
ROIFMAN SYNDROME; RFMN	0.004399784	0.15078597621577164
OCCIPITAL HORN SYNDROME	0.004399784	0.15078597621577164
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004395649	0.15064426471092224
THANATOPHORIC DYSPLASIA	0.004395649	0.15064426471092224
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004395649	0.15064426471092224
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00431758	0.1479687446451215
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00431758	0.1479687446451215
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00431758	0.1479687446451215
HEREDITARY OROTIC ACIDURIA	0.004315244	0.14788868706946778
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004315244	0.14788868706946778
OPITZ G/BBB SYNDROME	0.004315244	0.14788868706946778
TREACHER-COLLINS SYNDROME	0.004315244	0.14788868706946778
JOUBERT SYNDROME 10	0.004315244	0.14788868706946778
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004315244	0.14788868706946778
OGDEN SYNDROME; OGDNS	0.004315244	0.14788868706946778
RING CHROMOSOME 10 SYNDROME	0.0043111090000000005	0.1477469755646184
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0043111090000000005	0.1477469755646184
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0043111090000000005	0.1477469755646184
17Q24.2 MICRODELETION SYNDROME	0.0043111090000000005	0.1477469755646184
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1464580691593269
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1464580691593269
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.1464580691593269
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0042734999999999995	0.1464580691593269
BLADDER EXSTROPHY	0.0042734999999999995	0.1464580691593269
COOPER-JABS SYNDROME	0.0042734999999999995	0.1464580691593269
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.1464580691593269
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.1464580691593269
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1464580691593269
EHLERS-DANLOS SYNDROME, TYPE I	0.0042734999999999995	0.1464580691593269
ACHONDROGENESIS	0.0042734999999999995	0.1464580691593269
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.1464580691593269
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0042734999999999995	0.1464580691593269
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1464580691593269
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.0042734999999999995	0.1464580691593269
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0042734999999999995	0.1464580691593269
GAPO SYNDROME	0.0042734999999999995	0.1464580691593269
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1464580691593269
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0042734999999999995	0.1464580691593269
LEPRECHAUNISM	0.0042734999999999995	0.1464580691593269
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1464580691593269
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.1464580691593269
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.1464580691593269
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.0042734999999999995	0.1464580691593269
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1464580691593269
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1464580691593269
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1464580691593269
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.1464580691593269
PROGEROID SYNDROME, PETTY TYPE	0.0042734999999999995	0.1464580691593269
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.1464580691593269
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0042734999999999995	0.1464580691593269
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1464580691593269
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.1464580691593269
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0042734999999999995	0.1464580691593269
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1464580691593269
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1464580691593269
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0042734999999999995	0.1464580691593269
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0042734999999999995	0.1464580691593269
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1464580691593269
FLOATING-HARBOR SYNDROME	0.0042734999999999995	0.1464580691593269
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.1464580691593269
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00415799	0.14249940025360705
3Q27.3 MICRODELETION SYNDROME	0.00415799	0.14249940025360705
JUVENILE POLYPOSIS OF INFANCY	0.00415799	0.14249940025360705
SOTOS SYNDROME 2	0.00415799	0.14249940025360705
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00415799	0.14249940025360705
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.13755851811234104
FRONTONASAL DYSPLASIA 1; FND1	0.0040138199999999995	0.13755851811234104
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.13755851811234104
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.13755851811234104
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0040138199999999995	0.13755851811234104
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.13755851811234104
SHORT SYNDROME	0.0040138199999999995	0.13755851811234104
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.13755851811234104
CHARLIE M SYNDROME	0.0040138199999999995	0.13755851811234104
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.13755851811234104
CRANIOECTODERMAL DYSPLASIA 1	0.0040138199999999995	0.13755851811234104
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.13755851811234104
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.13755851811234104
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.13755851811234104
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0040138199999999995	0.13755851811234104
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.13755851811234104
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.0040138199999999995	0.13755851811234104
GORLIN SYNDROME	0.0040138199999999995	0.13755851811234104
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0040138199999999995	0.13755851811234104
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0040138199999999995	0.13755851811234104
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0040138199999999995	0.13755851811234104
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.13755851811234104
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.13687357346036533
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.13687357346036533
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.13687357346036533
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.13687357346036533
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.13687357346036533
RIDDLE SYNDROME	0.003993834	0.13687357346036533
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.13687357346036533
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.13687357346036533
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.13687357346036533
FRIED SYNDROME	0.003993834	0.13687357346036533
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.13687357346036533
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.13687357346036533
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.13687357346036533
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.13687357346036533
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.003993834	0.13687357346036533
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.13673186195551595
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.003989699	0.13673186195551595
BEHÇET DISEASE	0.003989699	0.13673186195551595
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13673186195551595
DYSEQUILIBRIUM SYNDROME	0.003989699	0.13673186195551595
CHOREOACANTHOCYTOSIS	0.003989699	0.13673186195551595
LYNCH SYNDROME	0.003989699	0.13673186195551595
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.13673186195551595
ATAXIA-TELANGIECTASIA	0.003989699	0.13673186195551595
KALLMANN SYNDROME	0.003989699	0.13673186195551595
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.13673186195551595
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.13673186195551595
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003989699	0.13673186195551595
SUBEPENDYMOMA	0.003989699	0.13673186195551595
EPENDYMOMA	0.003989699	0.13673186195551595
TENORIO SYNDROME; TNORS	0.003989699	0.13673186195551595
CENTRONUCLEAR MYOPATHY	0.003989699	0.13673186195551595
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.13673186195551595
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.13673186195551595
KUFOR-RAKEB SYNDROME	0.003989699	0.13673186195551595
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.13673186195551595
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.13673186195551595
ALZHEIMER DISEASE 3; AD	0.003989699	0.13673186195551595
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.13673186195551595
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.13673186195551595
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.13673186195551595
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.13673186195551595
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.13673186195551595
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00385423	0.13208917372082662
FIBROCHONDROGENESIS	0.00385423	0.13208917372082662
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00385423	0.13208917372082662
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00385423	0.13208917372082662
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00385423	0.13208917372082662
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00385423	0.13208917372082662
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.003789673	0.12987672641283113
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0037896729999999995	0.12987672641283113
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0037896729999999995	0.12987672641283113
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0037896729999999995	0.12987672641283113
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0037896729999999995	0.12987672641283113
49,XXXXY SYNDROME	0.0037896729999999995	0.12987672641283113
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0037896729999999995	0.12987672641283113
JABERI-ELAHI SYNDROME; JABELS	0.0037896729999999995	0.12987672641283113
8P11.2 DELETION SYNDROME	0.0037896729999999995	0.12987672641283113
1Q21.1 MICRODUPLICATION SYNDROME	0.0037896729999999995	0.12987672641283113
DISTAL MONOSOMY 15Q	0.0037896729999999995	0.12987672641283113
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0037896729999999995	0.12987672641283113
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0037896729999999995	0.12987672641283113
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0037896729999999995	0.12987672641283113
ACROMELIC FRONTONASAL DYSPLASIA	0.0037896729999999995	0.12987672641283113
48,XXXY SYNDROME	0.0037896729999999995	0.12987672641283113
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0037896729999999995	0.12987672641283113
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00376969	0.12919188457452277
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00376969	0.12919188457452277
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00376969	0.12919188457452277
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00376969	0.12919188457452277
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00376969	0.12919188457452277
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00376969	0.12919188457452277
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00376969	0.12919188457452277
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00376969	0.12919188457452277
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00376969	0.12919188457452277
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00376969	0.12919188457452277
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00376969	0.12919188457452277
RING CHROMOSOME 1 SYNDROME	0.00376969	0.12919188457452277
FRONTOMETAPHYSEAL DYSPLASIA	0.00376969	0.12919188457452277
MONOSOMY 5P	0.00376969	0.12919188457452277
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00376969	0.12919188457452277
HYPERTELORISM, TEEBI TYPE; TBHS	0.00376969	0.12919188457452277
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00376969	0.12919188457452277
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00376969	0.12919188457452277
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00376969	0.12919188457452277
OTOPALATODIGITAL SYNDROME TYPE 1	0.00376969	0.12919188457452277
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00376969	0.12919188457452277
DISTAL MONOSOMY 10P	0.00376969	0.12919188457452277
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00344828	0.11817677096542034
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11817677096542034
POLYMYOSITIS	0.00344828	0.11817677096542034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11817677096542034
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.11817677096542034
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.11817677096542034
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11817677096542034
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11817677096542034
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11817677096542034
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11817677096542034
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11817677096542034
SPONASTRIME DYSPLASIA	0.00344828	0.11817677096542034
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11817677096542034
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.11817677096542034
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11817677096542034
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.11817677096542034
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11817677096542034
KENNEDY DISEASE	0.00344828	0.11817677096542034
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11817677096542034
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.11817677096542034
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11817677096542034
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11817677096542034
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11817677096542034
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.11817677096542034
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11817677096542034
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11817677096542034
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11817677096542034
NONAKA MYOPATHY	0.00344828	0.11817677096542034
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11817677096542034
MYOTONIA PERMANENS	0.00344828	0.11817677096542034
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11817677096542034
MYOTONIA FLUCTUANS	0.00344828	0.11817677096542034
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11817677096542034
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11817677096542034
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.11817677096542034
ROUSSY-LÉVY SYNDROME	0.00344828	0.11817677096542034
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.11817677096542034
MASA SYNDROME	0.00344828	0.11817677096542034
BRITTLE CORNEA SYNDROME	0.00344828	0.11817677096542034
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11817677096542034
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11817677096542034
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11817677096542034
DYSTONIA 23; DYT23	0.00344828	0.11817677096542034
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11817677096542034
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.11817677096542034
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11817677096542034
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11817677096542034
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11817677096542034
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11817677096542034
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11817677096542034
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11817677096542034
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11817677096542034
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11817677096542034
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.11817677096542034
CLASSIC GALACTOSEMIA	0.00344828	0.11817677096542034
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11817677096542034
BENIGN HEREDITARY CHOREA	0.00344828	0.11817677096542034
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11817677096542034
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11817677096542034
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11817677096542034
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11817677096542034
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11817677096542034
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11817677096542034
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11817677096542034
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11817677096542034
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11817677096542034
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11817677096542034
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11817677096542034
CYSTINOSIS	0.00344828	0.11817677096542034
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.11817677096542034
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11817677096542034
THORACOMELIC DYSPLASIA	0.00344828	0.11817677096542034
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11817677096542034
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11817677096542034
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11817677096542034
TRISOMY XQ28	0.00344828	0.11817677096542034
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11817677096542034
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00344828	0.11817677096542034
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11817677096542034
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11817677096542034
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11817677096542034
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00344828	0.11817677096542034
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11817677096542034
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.11817677096542034
ATAXIA WITH VITAMIN E DEFICIENCY	0.00344828	0.11817677096542034
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11817677096542034
MANGANESE POISONING	0.00344828	0.11817677096542034
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11817677096542034
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.11817677096542034
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11817677096542034
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11817677096542034
KUSKOKWIM SYNDROME	0.00344828	0.11817677096542034
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11817677096542034
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11817677096542034
PSEUDOACHONDROPLASIA	0.00344828	0.11817677096542034
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11817677096542034
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11817677096542034
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11817677096542034
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11817677096542034
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.11817677096542034
NEMALINE MYOPATHY 6	0.00344828	0.11817677096542034
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11817677096542034
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.11817677096542034
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.11817677096542034
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11817677096542034
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11817677096542034
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11817677096542034
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.11817677096542034
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11817677096542034
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11817677096542034
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.003439913	0.1178900236471435
PRADER-WILLI SYNDROME; PWS	0.003439913	0.1178900236471435
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.003439913	0.1178900236471435
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.003439913	0.1178900236471435
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.003439913	0.1178900236471435
SPINOCEREBELLAR ATAXIA TYPE 13	0.003439913	0.1178900236471435
CODAS SYNDROME	0.003439913	0.1178900236471435
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.003439913	0.1178900236471435
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003439913	0.1178900236471435
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003439913	0.1178900236471435
VICI SYNDROME; VICIS	0.003439913	0.1178900236471435
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.003439913	0.1178900236471435
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003439913	0.1178900236471435
KETOADIPICACIDURIA	0.003439913	0.1178900236471435
ATELOSTEOGENESIS TYPE III	0.003248254	0.11132163542273553
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.003248254	0.11132163542273553
LARSEN-LIKE SYNDROME	0.003248254	0.11132163542273553
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.11132163542273553
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.003248254	0.11132163542273553
ROTHMUND-THOMSON SYNDROME	0.003248254	0.11132163542273553
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.11132163542273553
DIAPHANOSPONDYLODYSOSTOSIS	0.003248254	0.11132163542273553
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003248254	0.11132163542273553
RAHMAN SYNDROME	0.003248254	0.11132163542273553
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003248254	0.11132163542273553
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.11132163542273553
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.11132163542273553
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.11132163542273553
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.003248254	0.11132163542273553
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.003248254	0.11132163542273553
SECKEL SYNDROME 9; SCKL9	0.003248254	0.11132163542273553
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.003248254	0.11132163542273553
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.11132163542273553
MOSAIC TRISOMY 9	0.003248254	0.11132163542273553
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.11132163542273553
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.11117992391788616
ISOLATED SPINA BIFIDA	0.0032441189999999997	0.11117992391788616
CYSTATHIONINURIA	0.0032441189999999997	0.11117992391788616
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.11117992391788616
MARDEN-WALKER SYNDROME	0.0032441189999999997	0.11117992391788616
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0032441189999999997	0.11117992391788616
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.11117992391788616
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0032441189999999997	0.11117992391788616
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0032441189999999997	0.11117992391788616
HOLOPROSENCEPHALY	0.003136153	0.10747979711436308
GRACILE BONE DYSPLASIA; GCLEB	0.003136153	0.10747979711436308
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0031361529999999996	0.10747979711436305
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0031361529999999996	0.10747979711436305
COWDEN SYNDROME	0.0031361529999999996	0.10747979711436305
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0031361529999999996	0.10747979711436305
MICRO SYNDROME	0.0030516130000000003	0.10458250796805925
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.0030516130000000003	0.10458250796805925
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0030516130000000003	0.10458250796805925
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0030516130000000003	0.10458250796805925
C SYNDROME	0.0030516130000000003	0.10458250796805925
COFFIN-SIRIS SYNDROME	0.0030516130000000003	0.10458250796805925
SIALURIA	0.0030516130000000003	0.10458250796805925
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0030516130000000003	0.10458250796805925
BOHRING-OPITZ SYNDROME	0.0030516130000000003	0.10458250796805925
KABUKI SYNDROME 1	0.0030516130000000003	0.10458250796805925
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0030516130000000003	0.10458250796805925
BOHRING-OPITZ SYNDROME	0.0030516130000000003	0.10458250796805925
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0030516130000000003	0.10458250796805925
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0030516130000000003	0.10458250796805925
OCULOECTODERMAL SYNDROME; OES	0.0030516130000000003	0.10458250796805925
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0030516130000000003	0.10458250796805925
CHROMOSOME 1P35 DELETION SYNDROME	0.0030516130000000003	0.10458250796805925
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0030516130000000003	0.10458250796805925
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0030516130000000003	0.10458250796805925
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0030516130000000003	0.10458250796805925
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0030516130000000003	0.10458250796805925
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0030516130000000003	0.10458250796805925
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0030516130000000003	0.10458250796805925
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.10458250796805922
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.003051613	0.10458250796805922
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.10458250796805922
8Q24.3 MICRODELETION SYNDROME	0.003051613	0.10458250796805922
DUCHENNE MUSCULAR DYSTROPHY	0.0028984939999999997	0.09933493265704788
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0028984939999999997	0.09933493265704788
SPINOCEREBELLAR ATAXIA TYPE 7	0.0028984939999999997	0.09933493265704788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0028984939999999997	0.09933493265704788
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028984939999999997	0.09933493265704788
BRAIN-LUNG-THYROID SYNDROME	0.0028984939999999997	0.09933493265704788
DYSTONIA 28, CHILDHOOD-ONSET	0.0028984939999999997	0.09933493265704788
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0028984939999999997	0.09933493265704788
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0028984939999999997	0.09933493265704788
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0028984939999999997	0.09933493265704788
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0028984939999999997	0.09933493265704788
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.0028984939999999997	0.09933493265704788
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0028984939999999997	0.09933493265704788
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0028984939999999997	0.09933493265704788
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.09933493265704788
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0028984939999999997	0.09933493265704788
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0028984939999999997	0.09933493265704788
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.0028984939999999997	0.09933493265704788
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0028984939999999997	0.09933493265704788
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.002894359	0.09919322115219852
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002894359	0.09919322115219852
PRADER-WILLI SYNDROME	0.002894359	0.09919322115219852
47,XYY SYNDROME	0.002894359	0.09919322115219852
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002894359	0.09919322115219852
EPISODIC ATAXIA, TYPE 6	0.002894359	0.09919322115219852
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002894359	0.09919322115219852
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.002894359	0.09919322115219852
BETA-KETOTHIOLASE DEFICIENCY	0.002894359	0.09919322115219852
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002894359	0.09919322115219852
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002894359	0.09919322115219852
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.002894359	0.09919322115219852
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.002894359	0.09919322115219852
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002894359	0.09919322115219852
CYCLIC VOMITING SYNDROME	0.002894359	0.09919322115219852
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.002894359	0.09919322115219852
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002894359	0.09919322115219852
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002894359	0.09919322115219852
CAMOS SYNDROME	0.002894359	0.09919322115219852
MICROPHTHALMIA, SYNDROMIC 1	0.002894359	0.09919322115219852
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.09919322115219852
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002894359	0.09919322115219852
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.002894359	0.09919322115219852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002894359	0.09919322115219852
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002894359	0.09919322115219852
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002894359	0.09919322115219852
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.002894359	0.09919322115219852
LISSENCEPHALY 3; LIS3	0.002894359	0.09919322115219852
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002892023	0.09911316357654477
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.002892023	0.09911316357654477
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002892023	0.09911316357654477
GABA-TRANSAMINASE DEFICIENCY	0.002892023	0.09911316357654477
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002892023	0.09911316357654477
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002892023	0.09911316357654477
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002892023	0.09911316357654477
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.002892023	0.09911316357654477
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002892023	0.09911316357654477
15Q11Q13 MICRODUPLICATION SYNDROME	0.002892023	0.09911316357654477
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002892023	0.09911316357654477
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002892023	0.09911316357654477
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.002892023	0.09911316357654477
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002892023	0.09911316357654477
LUSCAN-LUMISH SYNDROME; LLS	0.002892023	0.09911316357654477
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002892023	0.09911316357654477
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002892023	0.09911316357654477
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002892023	0.09911316357654477
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002892023	0.09911316357654477
CHROMOSOME 16P13.3 DELETION SYNDROME	0.002892023	0.09911316357654477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002892023	0.09911316357654477
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002892023	0.09911316357654477
MEVALONIC ACIDURIA	0.002892023	0.09911316357654477
MONOSOMY 9P	0.002892023	0.09911316357654477
22Q11.2 MICRODUPLICATION SYNDROME	0.002892023	0.09911316357654477
19P13.13 MICRODELETION SYNDROME	0.002892023	0.09911316357654477
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.002892023	0.09911316357654477
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002892023	0.09911316357654477
611961 STEVENSON-CAREY SYNDROME	0.002892023	0.09911316357654477
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0027026999999999997	0.09262483292779053
ATELOSTEOGENESIS, TYPE II	0.0027026999999999997	0.09262483292779053
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.09262483292779053
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.09262483292779053
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.09262483292779053
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0027026999999999997	0.09262483292779053
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0027026999999999997	0.09262483292779053
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.09262483292779053
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.09262483292779053
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.09262483292779053
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0027026999999999997	0.09262483292779053
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.09262483292779053
CRANE-HEISE SYNDROME	0.0027026999999999997	0.09262483292779053
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.09262483292779053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.09262483292779053
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.09262483292779053
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0027026999999999997	0.09262483292779053
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0027026999999999997	0.09262483292779053
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0027026999999999997	0.09262483292779053
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.09262483292779053
RENAL AGENESIS	0.0027026999999999997	0.09262483292779053
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0027026999999999997	0.09262483292779053
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.09262483292779053
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0027026999999999997	0.09262483292779053
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0027026999999999997	0.09262483292779053
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0027026999999999997	0.09262483292779053
BRUCK SYNDROME 2	0.0027026999999999997	0.09262483292779053
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0027026999999999997	0.09262483292779053
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.09262483292779053
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.09262483292779053
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09262483292779053
NIEVERGELT SYNDROME	0.0027026999999999997	0.09262483292779053
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.09262483292779053
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.09262483292779053
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0027026999999999997	0.09262483292779053
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.09262483292779053
ULBRIGHT-HODES SYNDROME	0.0027026999999999997	0.09262483292779053
MEIER-GORLIN SYNDROME 1; MGORS1	0.0027026999999999997	0.09262483292779053
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0027026999999999997	0.09262483292779053
FEMORAL-FACIAL SYNDROME	0.0027026999999999997	0.09262483292779053
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.09262483292779053
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.09262483292779053
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.0027026999999999997	0.09262483292779053
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.09262483292779053
BRUCK SYNDROME	0.0027026999999999997	0.09262483292779053
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0027026999999999997	0.09262483292779053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.0027026999999999997	0.09262483292779053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.0027026999999999997	0.09262483292779053
NAIL-PATELLA SYNDROME	0.0027026999999999997	0.09262483292779053
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027026999999999997	0.09262483292779053
STÜVE-WIEDEMANN SYNDROME	0.0027026999999999997	0.09262483292779053
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.09262483292779053
TIBIAL HEMIMELIA	0.0027026999999999997	0.09262483292779053
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0027026999999999997	0.09262483292779053
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.09262483292779053
LAMBERT SYNDROME	0.0027026999999999997	0.09262483292779053
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.09262483292779053
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.09262483292779053
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.09262483292779053
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.09262483292779053
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0027026999999999997	0.09262483292779053
PRUNE BELLY SYNDROME	0.0027026999999999997	0.09262483292779053
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0027026999999999997	0.09262483292779053
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0027026999999999997	0.09262483292779053
FIBULAR HEMIMELIA	0.0027026999999999997	0.09262483292779053
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.09262483292779053
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.0027026999999999997	0.09262483292779053
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09262483292779053
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.0027026999999999997	0.09262483292779053
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0027026999999999997	0.09262483292779053
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0027026999999999997	0.09262483292779053
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.0027026999999999997	0.09262483292779053
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.0027026999999999997	0.09262483292779053
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0027026999999999997	0.09262483292779053
MICROTRIPLICATION 11Q24.1	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.09262483292779053
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0027026999999999997	0.09262483292779053
CLOACAL EXSTROPHY	0.0027026999999999997	0.09262483292779053
AMYLOIDOSIS	0.0027026999999999997	0.09262483292779053
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0027026999999999997	0.09262483292779053
MASA SYNDROME	0.0027026999999999997	0.09262483292779053
INIENCEPHALY	0.0027026999999999997	0.09262483292779053
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09262483292779053
PELVIS-SHOULDER DYSPLASIA	0.0027026999999999997	0.09262483292779053
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.09262483292779053
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0027026999999999997	0.09262483292779053
BRACHYDACTYLY TYPE A4	0.0027026999999999997	0.09262483292779053
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0027026999999999997	0.09262483292779053
BRACHYDACTYLY TYPE A1	0.0027026999999999997	0.09262483292779053
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.09262483292779053
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.09262483292779053
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.08892470612426744
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.08892470612426744
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.08892470612426744
CHARGE SYNDROME	0.0025947339999999996	0.08892470612426744
TETRASOMY X	0.0025947339999999996	0.08892470612426744
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.08892470612426744
TEMTAMY SYNDROME	0.0025947339999999996	0.08892470612426744
ROBERTS SYNDROME	0.0025947339999999996	0.08892470612426744
CODAS SYNDROME	0.0025947339999999996	0.08892470612426744
OROFACIODIGITAL SYNDROME VI	0.0025947339999999996	0.08892470612426744
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.08892470612426744
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.08892470612426744
BARATELA-SCOTT SYNDROME	0.0025947339999999996	0.08892470612426744
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.08892470612426744
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.08892470612426744
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0025947339999999996	0.08892470612426744
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.08892470612426744
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.08892470612426744
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.08892470612426744
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.08892470612426744
PHENOBARBITAL EMBRYOPATHY	0.0025947339999999996	0.08892470612426744
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.08892470612426744
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.08892470612426744
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.08892470612426744
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0025947339999999996	0.08892470612426744
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.08892470612426744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.08892470612426744
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0025947339999999996	0.08892470612426744
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0025947339999999996	0.08892470612426744
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002590599	0.08878299461941808
CONO-SPONDYLAR DYSPLASIA	0.002590599	0.08878299461941808
CRANIOSYNOSTOSIS 2	0.002590599	0.08878299461941808
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.08878299461941808
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.002590599	0.08878299461941808
DUBOWITZ SYNDROME	0.002590599	0.08878299461941808
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002590599	0.08878299461941808
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.08878299461941808
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.08878299461941808
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.08878299461941808
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002590599	0.08878299461941808
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.08878299461941808
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002590599	0.08878299461941808
PGM3-CDG	0.002590599	0.08878299461941808
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0025101940000000003	0.08602741697796362
STEEL SYNDROME; STLS	0.0025101940000000003	0.08602741697796362
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0025101940000000003	0.08602741697796362
SWEENEY-COX SYNDROME; SWCOS	0.0025101940000000003	0.08602741697796362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.08602741697796362
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.08602741697796362
MIETENS SYNDROME	0.0025101940000000003	0.08602741697796362
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0025101940000000003	0.08602741697796362
CHROMOSOME 18P DELETION SYNDROME	0.0025101940000000003	0.08602741697796362
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.08602741697796362
8Q12 MICRODUPLICATION SYNDROME	0.0025101940000000003	0.08602741697796362
PENTASOMY X	0.0025101940000000003	0.08602741697796362
8Q22.1 MICRODELETION SYNDROME	0.0025101940000000003	0.08602741697796362
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0025101940000000003	0.08602741697796362
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.08602741697796362
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.08602741697796362
SYNDROMIC DIARRHEA	0.0025101940000000003	0.08602741697796362
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.08602741697796362
HURLER SYNDROME	0.0025101940000000003	0.08602741697796362
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0025101940000000003	0.08602741697796362
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0025101940000000003	0.08602741697796362
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.08602741697796362
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0025101940000000003	0.08602741697796362
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0025101940000000003	0.08602741697796362
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.08602741697796362
LIG4 SYNDROME	0.0025101940000000003	0.08602741697796362
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.08602741697796362
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.08602741697796362
TRISOMY 12P	0.0025101940000000003	0.08602741697796362
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.08588570547311423
FRYNS SYNDROME	0.002506059	0.08588570547311423
COFS SYNDROME	0.002506059	0.08588570547311423
8P INVERTED DUPLICATION/DELETION SYNDROME	0.002506059	0.08588570547311423
RENPENNING SYNDROME 1; RENS1	0.002506059	0.08588570547311423
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.08588570547311423
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002506059	0.08588570547311423
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.002506059	0.08588570547311423
ZUNICH NEUROECTODERMAL SYNDROME	0.002506059	0.08588570547311423
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.002506059	0.08588570547311423
INTELLECTUAL DISABILITY, WOLFF TYPE	0.002506059	0.08588570547311423
OHDO SYNDROME	0.002506059	0.08588570547311423
GLUTAMINE DEFICIENCY, CONGENITAL	0.002506059	0.08588570547311423
FILIPPI SYNDROME; FLPIS	0.002506059	0.08588570547311423
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002506059	0.08588570547311423
ACROCARDIOFACIAL SYNDROME	0.002506059	0.08588570547311423
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002506059	0.08588570547311423
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.08588570547311423
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002506059	0.08588570547311423
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002506059	0.08588570547311423
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.08588570547311423
HENNEKAM-BEEMER SYNDROME	0.002506059	0.08588570547311423
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.08588570547311423
SALIH MYOPATHY; SALMY	0.00235294	0.08063813016210289
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00235294	0.08063813016210289
NEUTRAL LIPID STORAGE MYOPATHY	0.00235294	0.08063813016210289
GILLESPIE SYNDROME; GLSP	0.00235294	0.08063813016210289
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.08063813016210289
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00235294	0.08063813016210289
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00235294	0.08063813016210289
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00235294	0.08063813016210289
CAP MYOPATHY	0.00235294	0.08063813016210289
AMISH NEMALINE MYOPATHY	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.08063813016210289
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.08063813016210289
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.08063813016210289
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.08063813016210289
INTERMEDIATE NEMALINE MYOPATHY	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.00235294	0.08063813016210289
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.08063813016210289
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.08063813016210289
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00235294	0.08063813016210289
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00235294	0.08063813016210289
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00235294	0.08063813016210289
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00235294	0.08063813016210289
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00235294	0.08063813016210289
MEIER-GORLIN SYNDROME 5; MGORS5	0.00235294	0.08063813016210289
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00235294	0.08063813016210289
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00235294	0.08063813016210289
GLYCOGEN STORAGE DISEASE IXA	0.00235294	0.08063813016210289
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00235294	0.08063813016210289
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00235294	0.08063813016210289
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.08063813016210289
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00235294	0.08063813016210289
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00235294	0.08063813016210289
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA 13	0.00235294	0.08063813016210289
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00235294	0.08063813016210289
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00235294	0.08063813016210289
MENTAL RETARDATION, X-LINKED 19	0.00235294	0.08063813016210289
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.08063813016210289
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00235294	0.08063813016210289
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00235294	0.08063813016210289
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00235294	0.08063813016210289
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00235294	0.08063813016210289
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00235294	0.08063813016210289
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00235294	0.08063813016210289
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.08063813016210289
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00235294	0.08063813016210289
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00235294	0.08063813016210289
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.08063813016210289
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.08063813016210289
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00235294	0.08063813016210289
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00235294	0.08063813016210289
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00235294	0.08063813016210289
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00235294	0.08063813016210289
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.08063813016210289
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00235294	0.08063813016210289
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00235294	0.08063813016210289
MYOPATHY, CENTRONUCLEAR, 5	0.00235294	0.08063813016210289
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00235294	0.08063813016210289
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00235294	0.08063813016210289
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00235294	0.08063813016210289
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00235294	0.08063813016210289
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00235294	0.08063813016210289
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00235294	0.08063813016210289
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00235294	0.08063813016210289
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.00235294	0.08063813016210289
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00235294	0.08063813016210289
USHER SYNDROME, TYPE IF	0.00235294	0.08063813016210289
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00235294	0.08063813016210289
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00235294	0.08063813016210289
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.08063813016210289
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00235294	0.08063813016210289
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00235294	0.08063813016210289
TEMPLE SYNDROME	0.00235294	0.08063813016210289
PURE MITOCHONDRIAL MYOPATHY	0.00235294	0.08063813016210289
SENGERS SYNDROME	0.00235294	0.08063813016210289
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.00235294	0.08063813016210289
SILVER-RUSSELL SYNDROME	0.00235294	0.08063813016210289
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00235294	0.08063813016210289
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00235294	0.08063813016210289
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.08063813016210289
LESCH-NYHAN SYNDROME; LNS	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.08063813016210289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.08063813016210289
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00235294	0.08063813016210289
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 4	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 1; NEM1	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00235294	0.08063813016210289
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00235294	0.08063813016210289
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00235294	0.08063813016210289
BRUNNER SYNDROME; BRNRS	0.00235294	0.08063813016210289
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00235294	0.08063813016210289
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00235294	0.08063813016210289
EPISODIC ATAXIA TYPE 1	0.00235294	0.08063813016210289
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00235294	0.08063813016210289
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00235294	0.08063813016210289
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00235294	0.08063813016210289
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00235294	0.08063813016210289
BETHLEM MYOPATHY 1	0.00235294	0.08063813016210289
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00235294	0.08063813016210289
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00235294	0.08063813016210289
TEMPLE SYNDROME	0.00235294	0.08063813016210289
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 3; NEM3	0.00235294	0.08063813016210289
NEMALINE MYOPATHY 2; NEM2	0.00235294	0.08063813016210289
COLE-CARPENTER SYNDROME	0.002350604	0.08055807258644916
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.08055807258644916
14Q22Q23 MICRODELETION SYNDROME	0.002350604	0.08055807258644916
XIA-GIBBS SYNDROME	0.002350604	0.08055807258644916
TRISOMY 17P	0.002350604	0.08055807258644916
RITSCHER-SCHINZEL SYNDROME 1	0.002350604	0.08055807258644916
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.002350604	0.08055807258644916
NOONAN SYNDROME 9; NS9	0.002350604	0.08055807258644916
CUTIS LAXA	0.002350604	0.08055807258644916
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002350604	0.08055807258644916
17P13.3 MICRODUPLICATION SYNDROME	0.002350604	0.08055807258644916
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002350604	0.08055807258644916
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.002350604	0.08055807258644916
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.002350604	0.08055807258644916
CHAR SYNDROME	0.002350604	0.08055807258644916
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.08055807258644916
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002350604	0.08055807258644916
NOONAN SYNDROME 5; NS5	0.002350604	0.08055807258644916
NOONAN SYNDROME 2; NS2	0.002350604	0.08055807258644916
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.002350604	0.08055807258644916
NOONAN SYNDROME 11; NS11	0.002350604	0.08055807258644916
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.002350604	0.08055807258644916
THAUVIN-ROBINET-FAIVRE SYNDROME	0.002350604	0.08055807258644916
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002350604	0.08055807258644916
CREE MENTAL RETARDATION SYNDROME	0.002350604	0.08055807258644916
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002350604	0.08055807258644916
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.002350604	0.08055807258644916
NOONAN SYNDROME 3; NS3	0.002350604	0.08055807258644916
MEVALONIC ACIDURIA; MEVA	0.002350604	0.08055807258644916
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002350604	0.08055807258644916
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.08055807258644916
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002350604	0.08055807258644916
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.08055807258644916
FRIAS SYNDROME	0.002350604	0.08055807258644916
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002350604	0.08055807258644916
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0023464690000000003	0.08041636108159979
PROTEUS SYNDROME	0.0023464690000000003	0.08041636108159979
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0023464690000000003	0.08041636108159979
AUTISM, SUSCEPTIBILITY TO, 18	0.0023464690000000003	0.08041636108159979
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0023464690000000003	0.08041636108159979
ZIMMERMANN-LABAND SYNDROME	0.0023464690000000003	0.08041636108159979
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0023464690000000003	0.08041636108159979
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0023464690000000003	0.08041636108159979
ATKIN-FLAITZ SYNDROME	0.0023464690000000003	0.08041636108159979
MALAN OVERGROWTH SYNDROME	0.0023464690000000003	0.08041636108159979
MOMO SYNDROME	0.0023464690000000003	0.08041636108159979
LOWRY-MACLEAN SYNDROME	0.0023464690000000003	0.08041636108159979
CLARK-BARAITSER SYNDROME	0.0023464690000000003	0.08041636108159979
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0023464690000000003	0.08041636108159979
SMITH-FINEMAN-MYERS SYNDROME	0.0023464690000000003	0.08041636108159979
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.0023464690000000003	0.08041636108159979
2Q24 MICRODELETION SYNDROME	0.0023464690000000003	0.08041636108159979
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0023464690000000003	0.08041636108159979
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07022790362932245
JACOBSEN SYNDROME	0.00204918	0.07022790362932245
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07022790362932245
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07022790362932245
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07022790362932245
BRACHYDACTYLY, TYPE E	0.00204918	0.07022790362932245
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07022790362932245
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.07022790362932245
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07022790362932245
ATELOSTEOGENESIS TYPE II	0.00204918	0.07022790362932245
SATOYOSHI SYNDROME	0.00204918	0.07022790362932245
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.07022790362932245
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07022790362932245
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00204918	0.07022790362932245
SMITH-MAGENIS SYNDROME	0.00204918	0.07022790362932245
EIKEN SYNDROME	0.00204918	0.07022790362932245
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07022790362932245
FRONTORHINY	0.00204918	0.07022790362932245
2Q37 MONOSOMY	0.00204918	0.07022790362932245
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07022790362932245
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07022790362932245
GRANGE SYNDROME; GRNG	0.00204918	0.07022790362932245
HYPOCHONDROPLASIA	0.00204918	0.07022790362932245
JEUNE SYNDROME	0.00204918	0.07022790362932245
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07022790362932245
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07022790362932245
RHYNS SYNDROME; RHYNS	0.00204918	0.07022790362932245
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.07022790362932245
LAURENCE-MOON SYNDROME	0.00204918	0.07022790362932245
METATROPIC DYSPLASIA	0.00204918	0.07022790362932245
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07022790362932245
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07022790362932245
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.07022790362932245
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.07022790362932245
CLEIDOCRANIAL DYSPLASIA; CCD	0.00204918	0.07022790362932245
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.07022790362932245
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07022790362932245
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07022790362932245
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00204918	0.07022790362932245
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07022790362932245
LARSEN SYNDROME	0.00204918	0.07022790362932245
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07022790362932245
HYPOCHONDROPLASIA	0.00204918	0.07022790362932245
CAMPTOBRACHYDACTYLY	0.00204918	0.07022790362932245
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07022790362932245
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07022790362932245
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00204918	0.07022790362932245
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00204918	0.07022790362932245
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07022790362932245
SILLENCE SYNDROME	0.00204918	0.07022790362932245
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07022790362932245
OPSISMODYSPLASIA	0.00204918	0.07022790362932245
ABRUZZO-ERICKSON SYNDROME	0.00204918	0.07022790362932245
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07022790362932245
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00204918	0.07022790362932245
SYMPHALANGISM, DISTAL	0.00204918	0.07022790362932245
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07022790362932245
SYNDACTYLY, TYPE V	0.00204918	0.07022790362932245
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07022790362932245
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07022790362932245
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07022790362932245
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07022790362932245
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07022790362932245
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07022790362932245
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07022790362932245
RADIO-RENAL SYNDROME	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07022790362932245
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07022790362932245
WEYERS ACROFACIAL DYSOSTOSIS	0.00204918	0.07022790362932245
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07022790362932245
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07022790362932245
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07022790362932245
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07022790362932245
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00204918	0.07022790362932245
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07022790362932245
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07022790362932245
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07022790362932245
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.07022790362932245
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00204918	0.07022790362932245
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00204918	0.07022790362932245
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07022790362932245
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07022790362932245
ROIFMAN SYNDROME	0.00204918	0.07022790362932245
ISOLATED BRACHYCEPHALY	0.00204918	0.07022790362932245
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07022790362932245
WEILL-MARCHESANI SYNDROME	0.00204918	0.07022790362932245
PYCNODYSOSTOSIS	0.00204918	0.07022790362932245
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07022790362932245
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00204918	0.07022790362932245
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07022790362932245
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00204918	0.07022790362932245
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07022790362932245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07022790362932245
TETRALOGY OF FALLOT	0.00204918	0.07022790362932245
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07022790362932245
PROXIMAL SYMPHALANGISM	0.00204918	0.07022790362932245
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.07022790362932245
PSEUDOACHONDROPLASIA	0.00204918	0.07022790362932245
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.07022790362932245
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07022790362932245
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.07022790362932245
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07022790362932245
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07022790362932245
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07022790362932245
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07022790362932245
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00204918	0.07022790362932245
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07022790362932245
SUMMITT SYNDROME	0.00204918	0.07022790362932245
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07022790362932245
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07022790362932245
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07022790362932245
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.07022790362932245
BANKI SYNDROME	0.00204918	0.07022790362932245
LOWRY-WOOD SYNDROME	0.00204918	0.07022790362932245
EMERY-NELSON SYNDROME	0.00204918	0.07022790362932245
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07022790362932245
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07022790362932245
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07022790362932245
CHITAYAT SYNDROME	0.00204918	0.07022790362932245
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07022790362932245
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00204918	0.07022790362932245
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07022790362932245
CAMPTOBRACHYDACTYLY	0.00204918	0.07022790362932245
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.07022790362932245
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07022790362932245
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07022790362932245
GREENBERG DYSPLASIA	0.00204918	0.07022790362932245
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00204918	0.07022790362932245
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00204918	0.07022790362932245
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07022790362932245
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07022790362932245
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07022790362932245
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00204918	0.07022790362932245
PYCNODYSOSTOSIS	0.00204918	0.07022790362932245
AREDYLD SYNDROME	0.00204918	0.07022790362932245
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07022790362932245
COOKS SYNDROME	0.00204918	0.07022790362932245
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07022790362932245
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07022790362932245
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.07022790362932245
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07022790362932245
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.07022790362932245
CAMPOMELIA, CUMMING TYPE	0.00204918	0.07022790362932245
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07022790362932245
FEINGOLD SYNDROME	0.00204918	0.07022790362932245
PERIPHERAL DYSOSTOSIS	0.00204918	0.07022790362932245
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00204918	0.07022790362932245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.07022790362932245
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07022790362932245
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07022790362932245
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07022790362932245
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.07022790362932245
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07022790362932245
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00204918	0.07022790362932245
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07022790362932245
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07022790362932245
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.07022790362932245
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07022790362932245
ACROMICRIC DYSPLASIA	0.00204918	0.07022790362932245
CRANIOECTODERMAL DYSPLASIA	0.00204918	0.07022790362932245
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07022790362932245
ENG-STROM SYNDROME	0.00204918	0.07022790362932245
OROFACIODIGITAL SYNDROME IV; OFD4	0.00204918	0.07022790362932245
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00196464	0.06733061448301862
VELO-FACIAL-SKELETAL SYNDROME	0.00196464	0.06733061448301862
FEINGOLD SYNDROME 1; FGLDS1	0.00196464	0.06733061448301862
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06733061448301862
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00196464	0.06733061448301862
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.06733061448301862
ISOLATED TRIGONOCEPHALY	0.00196464	0.06733061448301862
FACIOCARDIORENAL SYNDROME	0.00196464	0.06733061448301862
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.06733061448301862
ZECHI-CEIDE SYNDROME	0.00196464	0.06733061448301862
3Q13 MICRODELETION SYNDROME	0.00196464	0.06733061448301862
RETINITIS PIGMENTOSA	0.00196464	0.06733061448301862
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.06733061448301862
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00196464	0.06733061448301862
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.06733061448301862
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00196464	0.06733061448301862
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00196464	0.06733061448301862
AXENFELD-RIEGER SYNDROME	0.00196464	0.06733061448301862
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.06733061448301862
FRONTONASAL DYSPLASIA	0.00196464	0.06733061448301862
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.06733061448301862
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.06733061448301862
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00196464	0.06733061448301862
SCLEROSTEOSIS 1; SOST1	0.00196464	0.06733061448301862
MEGALENCEPHALY	0.00196464	0.06733061448301862
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.06733061448301862
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06733061448301862
HAMAMY SYNDROME; HMMS	0.00196464	0.06733061448301862
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.06733061448301862
PIEBALDISM	0.00196464	0.06733061448301862
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00196464	0.06733061448301862
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.06733061448301862
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.06733061448301862
RING CHROMOSOME 6 SYNDROME	0.00196464	0.06733061448301862
JUNG SYNDROME	0.00196464	0.06733061448301862
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.06733061448301862
FACIOCARDIORENAL SYNDROME	0.00196464	0.06733061448301862
BEEMER LETHAL MALFORMATION SYNDROME	0.00196464	0.06733061448301862
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.06733061448301862
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.06733061448301862
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00196464	0.06733061448301862
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.06733061448301862
DUBOWITZ SYNDROME	0.00196464	0.06733061448301862
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00196464	0.06733061448301862
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.06733061448301862
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.06733061448301862
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00196464	0.06733061448301862
BOOMERANG DYSPLASIA	0.00196464	0.06733061448301862
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.06733061448301862
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00196464	0.06733061448301862
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00196464	0.06733061448301862
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.06733061448301862
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06733061448301862
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.06733061448301862
49,XXXYY SYNDROME	0.00196464	0.06733061448301862
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.06733061448301862
MARSHALL SYNDROME	0.00196464	0.06733061448301862
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00196464	0.06733061448301862
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00196464	0.06733061448301862
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00196464	0.06733061448301862
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.06733061448301862
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06733061448301862
RING CHROMOSOME 13 SYNDROME	0.00196464	0.06733061448301862
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.06733061448301862
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00196464	0.06733061448301862
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.06733061448301862
SHORT SYNDROME	0.00196464	0.06733061448301862
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.06733061448301862
SHELDON-HALL SYNDROME	0.00196464	0.06733061448301862
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.06733061448301862
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00196464	0.06733061448301862
MECKEL SYNDROME 12; MKS12	0.00196464	0.06733061448301862
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.06733061448301862
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.06733061448301862
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.06733061448301862
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.06733061448301862
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.06733061448301862
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.06733061448301862
MULIBREY NANISM	0.00196464	0.06733061448301862
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.06733061448301862
ACROOTOOCULAR SYNDROME	0.00180505	0.06186127009150417
ACRORENAL-MANDIBULAR SYNDROME	0.00180505	0.06186127009150417
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.06186127009150417
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.06186127009150417
CAT-EYE SYNDROME	0.00180505	0.06186127009150417
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.06186127009150417
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00180505	0.06186127009150417
TREACHER COLLINS SYNDROME 2; TCS2	0.00180505	0.06186127009150417
PROTEUS-LIKE SYNDROME	0.00180505	0.06186127009150417
PHAVER SYNDROME	0.00180505	0.06186127009150417
FRONTOMETAPHYSEAL DYSPLASIA	0.00180505	0.06186127009150417
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00180505	0.06186127009150417
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00180505	0.06186127009150417
NOONAN SYNDROME 10; NS10	0.00180505	0.06186127009150417
NON-DISTAL TRISOMY 10Q	0.00180505	0.06186127009150417
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00180505	0.06186127009150417
JUVENILE POLYPOSIS SYNDROME	0.00180505	0.06186127009150417
ANTLEY-BIXLER SYNDROME	0.00180505	0.06186127009150417
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.06186127009150417
8Q21.11 MICRODELETION SYNDROME	0.00180505	0.06186127009150417
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00180505	0.06186127009150417
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00180505	0.06186127009150417
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00180505	0.06186127009150417
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00180505	0.06186127009150417
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.06186127009150417
RESTRICTIVE DERMOPATHY	0.00180505	0.06186127009150417
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.06186127009150417
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.06186127009150417
MARFAN SYNDROME; MFS	0.00180505	0.06186127009150417
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00180505	0.06186127009150417
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.06186127009150417
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00180505	0.06186127009150417
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00180505	0.06186127009150417
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.06186127009150417
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00180505	0.06186127009150417
TREACHER COLLINS SYNDROME 3; TCS3	0.00180505	0.06186127009150417
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00180505	0.06186127009150417
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.06186127009150417
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.06186127009150417
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.06186127009150417
ALAGILLE SYNDROME	0.00180505	0.06186127009150417
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.06186127009150417
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00180505	0.06186127009150417
DIAMOND-BLACKFAN ANEMIA 1	0.00180505	0.06186127009150417
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.06186127009150417
MARFAN SYNDROME	0.00180505	0.06186127009150417
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.06186127009150417
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.06186127009150417
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.06186127009150417
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00180505	0.06186127009150417
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.06186127009150417
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00180505	0.06186127009150417
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00180505	0.06186127009150417
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.06186127009150417
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00180505	0.06186127009150417
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00180505	0.06186127009150417
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00180505	0.06186127009150417
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00180505	0.06186127009150417
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00180505	0.06186127009150417
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.06186127009150417
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00180505	0.06186127009150417
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.06186127009150417
RUVALCABA SYNDROME	0.00180505	0.06186127009150417
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.06186127009150417
LEGIUS SYNDROME	0.00180505	0.06186127009150417
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00180505	0.06186127009150417
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00180505	0.06186127009150417
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06186127009150417
APERT SYNDROME	0.00180505	0.06186127009150417
CENANI-LENZ SYNDROME	0.00180505	0.06186127009150417
NOONAN SYNDROME 4; NS4	0.00180505	0.06186127009150417
PRIMROSE SYNDROME; PRIMS	0.00180505	0.06186127009150417
THOMAS SYNDROME	0.00180505	0.06186127009150417
CEREBROFACIOTHORACIC DYSPLASIA	0.00180505	0.06186127009150417
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00180505	0.06186127009150417
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.06186127009150417
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00180505	0.06186127009150417
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00180505	0.06186127009150417
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00180505	0.06186127009150417
TRISOMY 1Q	0.00180505	0.06186127009150417
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00180505	0.06186127009150417
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.06186127009150417
PAI SYNDROME	0.00180505	0.06186127009150417
NAGER SYNDROME	0.00180505	0.06186127009150417
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00180505	0.06186127009150417
JOHNSON NEUROECTODERMAL SYNDROME	0.00180505	0.06186127009150417
NOONAN SYNDROME 8; NS8	0.00180505	0.06186127009150417
HARTSFIELD SYNDROME	0.00180505	0.06186127009150417
GMS SYNDROME	0.00180505	0.06186127009150417
SECKEL SYNDROME	0.00180505	0.06186127009150417
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06186127009150417
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03725189348504061
CITRULLINEMIA TYPE II	0.001086973	0.03725189348504061
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03725189348504061
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03725189348504061
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.03725189348504061
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03725189348504061
GALACTOSEMIA	0.001086973	0.03725189348504061
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03725189348504061
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.03725189348504061
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03725189348504061
COACH SYNDROME	0.001086973	0.03725189348504061
CITRULLINEMIA, CLASSIC	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.03725189348504061
MACDERMOT-WINTER SYNDROME	0.001086973	0.03725189348504061
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001086973	0.03725189348504061
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.03725189348504061
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.03725189348504061
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.03725189348504061
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03725189348504061
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03725189348504061
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03725189348504061
ISOVALERIC ACIDEMIA	0.001086973	0.03725189348504061
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.03725189348504061
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03725189348504061
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03725189348504061
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03725189348504061
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.03725189348504061
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03725189348504061
OPTIC PATHWAY GLIOMA	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.03725189348504061
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03725189348504061
SALLA DISEASE	0.001086973	0.03725189348504061
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.03725189348504061
RFT1-CDG	0.001086973	0.03725189348504061
HOLOPROSENCEPHALY 7	0.001086973	0.03725189348504061
SRD5A3-CDG	0.001086973	0.03725189348504061
XQ21 MICRODELETION SYNDROME	0.001086973	0.03725189348504061
CONGENITAL TOXOPLASMOSIS	0.001086973	0.03725189348504061
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03725189348504061
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.03725189348504061
RING CHROMOSOME 22 SYNDROME	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03725189348504061
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.03725189348504061
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.03725189348504061
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03725189348504061
ALG1-CDG	0.001086973	0.03725189348504061
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.03725189348504061
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.03725189348504061
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03725189348504061
HARTNUP DISORDER	0.001086973	0.03725189348504061
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.03725189348504061
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03725189348504061
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.03725189348504061
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.03725189348504061
2P21 MICRODELETION SYNDROME	0.001086973	0.03725189348504061
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03725189348504061
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.03725189348504061
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.03725189348504061
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.03725189348504061
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03725189348504061
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03725189348504061
PIERPONT SYNDROME	0.001086973	0.03725189348504061
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03725189348504061
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.03725189348504061
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.03725189348504061
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.03725189348504061
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.03725189348504061
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.03725189348504061
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03725189348504061
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.03725189348504061
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.03725189348504061
COFFIN-SIRIS SYNDROME 5	0.001086973	0.03725189348504061
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.03725189348504061
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03725189348504061
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.03725189348504061
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03725189348504061
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03725189348504061
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03725189348504061
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03725189348504061
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03725189348504061
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03725189348504061
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504061
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.03725189348504061
KEUTEL SYNDROME	0.001086973	0.03725189348504061
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.03725189348504061
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.03725189348504061
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.03725189348504061
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.03725189348504061
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.03725189348504061
PALLISTER-HALL SYNDROME	0.001086973	0.03725189348504061
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03725189348504061
EMANUEL SYNDROME	0.001086973	0.03725189348504061
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.03725189348504061
LEIGH SYNDROME; LS	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03725189348504061
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.03725189348504061
DISTAL MONOSOMY 1Q	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.03725189348504061
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.03725189348504061
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.03725189348504061
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03725189348504061
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.03725189348504061
SCHINDLER DISEASE, TYPE I	0.001086973	0.03725189348504061
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03725189348504061
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.03725189348504061
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03725189348504061
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.03725189348504061
STT3A-CDG	0.001086973	0.03725189348504061
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03725189348504061
STT3B-CDG	0.001086973	0.03725189348504061
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.03725189348504061
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.03725189348504061
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.03725189348504061
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.03725189348504061
DPAGT1-CDG	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.03725189348504061
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.03725189348504061
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.03725189348504061
ELEJALDE DISEASE	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03725189348504061
GRISCELLI SYNDROME	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.03725189348504061
KBG SYNDROME	0.001086973	0.03725189348504061
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03725189348504061
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03725189348504061
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03725189348504061
SSR4-CDG	0.001086973	0.03725189348504061
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.03725189348504061
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03725189348504061
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.03725189348504061
LISSENCEPHALY 1; LIS1	0.001086973	0.03725189348504061
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03725189348504061
PHACE ASSOCIATION	0.001086973	0.03725189348504061
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03725189348504061
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.03725189348504061
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03725189348504061
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03725189348504061
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.03725189348504061
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.03725189348504061
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.03725189348504061
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.03725189348504061
DISTAL TRISOMY 17Q	0.001086973	0.03725189348504061
TRISOMY X	0.001086973	0.03725189348504061
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03725189348504061
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.03725189348504061
PROPIONIC ACIDEMIA	0.001086973	0.03725189348504061
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.03725189348504061
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.03725189348504061
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03725189348504061
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.03725189348504061
WILSON-TURNER SYNDROME	0.001086973	0.03725189348504061
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.03725189348504061
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.03725189348504061
PHACE SYNDROME	0.001086973	0.03725189348504061
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.03725189348504061
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03725189348504061
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03725189348504061
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03725189348504061
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.03725189348504061
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03725189348504061
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03725189348504061
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.03725189348504061
48,XXYY SYNDROME	0.001086973	0.03725189348504061
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03725189348504061
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.03725189348504061
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.03725189348504061
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03725189348504061
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03725189348504061
FUCOSIDOSIS	0.001086973	0.03725189348504061
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.03725189348504061
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03725189348504061
KAGAMI-OGATA SYNDROME	0.001086973	0.03725189348504061
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03725189348504061
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03725189348504061
ALG3-CDG	0.001086973	0.03725189348504061
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.03725189348504061
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.03725189348504061
WYBURN-MASON SYNDROME	0.001086973	0.03725189348504061
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03725189348504061
CRANIOPHARYNGIOMA	0.001086973	0.03725189348504061
BAND HETEROTOPIA; BH	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03725189348504061
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.03725189348504061
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03725189348504061
NETHERTON SYNDROME	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03725189348504061
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001086973	0.03725189348504061
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.03725189348504061
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.03725189348504061
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03725189348504061
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.03725189348504061
GAUCHER DISEASE, TYPE II	0.001086973	0.03725189348504061
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.03725189348504061
ALSTRÖM SYNDROME	0.001086973	0.03725189348504061
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.03725189348504061
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.03725189348504061
WAISMAN SYNDROME; WSMN	0.001086973	0.03725189348504061
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03725189348504061
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.03725189348504061
EAST SYNDROME	0.001086973	0.03725189348504061
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001086973	0.03725189348504061
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03725189348504061
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.03725189348504061
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03725189348504061
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.03725189348504061
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03725189348504061
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03725189348504061
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.03725189348504061
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03725189348504061
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03725189348504061
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.03725189348504061
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03725189348504061
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03725189348504061
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03725189348504061
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.03725189348504061
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.03725189348504061
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03725189348504061
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03725189348504061
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.03725189348504061
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03725189348504061
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.03725189348504061
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.03725189348504061
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.03725189348504061
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03725189348504061
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.03725189348504061
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.03725189348504061
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.03725189348504061
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03725189348504061
CLASSIC PHENYLKETONURIA	0.001086973	0.03725189348504061
LISSENCEPHALY 4	0.001086973	0.03725189348504061
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.03725189348504061
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03725189348504061
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.03725189348504061
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001086973	0.03725189348504061
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.03725189348504061
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.03725189348504061
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.03725189348504061
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.03725189348504061
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.03725189348504061
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.03725189348504061
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03725189348504061
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.03725189348504061
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.03725189348504061
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.03725189348504061
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.03725189348504061
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.03725189348504061
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.03725189348504061
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.03725189348504061
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.03725189348504061
19P13.12 MICRODELETION SYNDROME	0.001086973	0.03725189348504061
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.03725189348504061
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.03725189348504061
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.03725189348504061
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.03725189348504061
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03725189348504061
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03725189348504061
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.03725189348504061
XQ25 DUPLICATION SYNDROME	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03725189348504061
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03725189348504061
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03725189348504061
PETTIGREW SYNDROME	0.001086973	0.03725189348504061
XP21 MICRODELETION SYNDROME	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03725189348504061
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03725189348504061
WALKER-WARBURG SYNDROME	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.03725189348504061
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03725189348504061
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03725189348504061
AICARDI-GOUTIÈRES SYNDROME	0.001086973	0.03725189348504061
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03725189348504061
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.03725189348504061
17Q12 MICRODELETION SYNDROME	0.001086973	0.03725189348504061
SULFOCYSTEINURIA	0.001086973	0.03725189348504061
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03725189348504061
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03725189348504061
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.03725189348504061
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03725189348504061
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.03725189348504061
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03725189348504061
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504061
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.03725189348504061
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.03725189348504061
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.03725189348504061
EMANUEL SYNDROME	0.001086973	0.03725189348504061
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504061
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03725189348504061
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.03725189348504061
HYDRANENCEPHALY	0.001086973	0.03725189348504061
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.03725189348504061
NARP SYNDROME	0.001086973	0.03725189348504061
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.03725189348504061
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03725189348504061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.03725189348504061
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03725189348504061
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.03725189348504061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03725189348504061
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.03725189348504061
LEBER CONGENITAL AMAUROSIS	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.03725189348504061
TIMOTHY SYNDROME; TS	0.001086973	0.03725189348504061
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.03725189348504061
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.03725189348504061
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.03725189348504061
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.03725189348504061
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.03725189348504061
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.03725189348504061
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03725189348504061
MAPLE SYRUP URINE DISEASE	0.001086973	0.03725189348504061
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03725189348504061
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03725189348504061
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.03725189348504061
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.018696802494944993
MEDULLOBLASTOMA	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.018696802494944993
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.018696802494944993
TRANSALDOLASE DEFICIENCY	0.000545554	0.018696802494944993
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.018696802494944993
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.018696802494944993
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.018696802494944993
ARIMA SYNDROME	0.000545554	0.018696802494944993
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.018696802494944993
MECKEL SYNDROME 13; MKS13	0.000545554	0.018696802494944993
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.018696802494944993
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.018696802494944993
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.018696802494944993
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.018696802494944993
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.018696802494944993
NETHERTON SYNDROME; NETH	0.000545554	0.018696802494944993
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.018696802494944993
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.018696802494944993
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.018696802494944993
JOUBERT SYNDROME 2	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.018696802494944993
48,XYYY SYNDROME	0.000545554	0.018696802494944993
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.018696802494944993
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.018696802494944993
CULLER-JONES SYNDROME; CJS	0.000545554	0.018696802494944993
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.018696802494944993
BRESEK SYNDROME	0.000545554	0.018696802494944993
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.018696802494944993
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018696802494944993
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.018696802494944993
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.018696802494944993
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.018696802494944993
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.018696802494944993
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.018696802494944993
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.018696802494944993
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.018696802494944993
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.018696802494944993
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.018696802494944993
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.018696802494944993
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.018696802494944993
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.018696802494944993
MUCOLIPIDOSIS IV; ML4	0.000545554	0.018696802494944993
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.018696802494944993
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.018696802494944993
CDAGS SYNDROME	0.000545554	0.018696802494944993
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.018696802494944993
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.018696802494944993
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.018696802494944993
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.018696802494944993
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.018696802494944993
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.018696802494944993
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.018696802494944993
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.018696802494944993
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.018696802494944993
CURRY-JONES SYNDROME	0.000545554	0.018696802494944993
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.018696802494944993
JOUBERT SYNDROME 21	0.000545554	0.018696802494944993
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944993
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.018696802494944993
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.018696802494944993
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.018696802494944993
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.018696802494944993
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.018696802494944993
TRANSKETOLASE DEFICIENCY	0.000545554	0.018696802494944993
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.018696802494944993
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.018696802494944993
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.018696802494944993
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.018696802494944993
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.018696802494944993
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.018696802494944993
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.018696802494944993
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.018696802494944993
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.018696802494944993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.018696802494944993
JAWAD SYNDROME	0.000545554	0.018696802494944993
LOWRY-MACLEAN SYNDROME	0.000545554	0.018696802494944993
8P23.1 DUPLICATION SYNDROME	0.000545554	0.018696802494944993
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.018696802494944993
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.018696802494944993
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.018696802494944993
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.018696802494944993
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.018696802494944993
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.018696802494944993
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.018696802494944993
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.018696802494944993
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.018696802494944993
LIG4 SYNDROME	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.018696802494944993
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.018696802494944993
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.018696802494944993
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.018696802494944993
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.018696802494944993
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.018696802494944993
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.018696802494944993
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.018696802494944993
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.018696802494944993
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.018696802494944993
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.018696802494944993
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.018696802494944993
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.018696802494944993
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.018696802494944993
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.018696802494944993
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.018696802494944993
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.018696802494944993
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.018696802494944993
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.018696802494944993
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.018696802494944993
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.018696802494944993
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.018696802494944993
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.018696802494944993
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.018696802494944993
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.018696802494944993
SECKEL SYNDROME 8; SCKL8	0.000545554	0.018696802494944993
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.018696802494944993
JOUBERT SYNDROME 15	0.000545554	0.018696802494944993
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.018696802494944993
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.018696802494944993
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.018696802494944993
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.018696802494944993
REVESZ SYNDROME	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.018696802494944993
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.018696802494944993
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.018696802494944993
HYDROXYKYNURENINURIA	0.000545554	0.018696802494944993
WAARDENBURG-SHAH SYNDROME	0.000545554	0.018696802494944993
JOUBERT SYNDROME 26	0.000545554	0.018696802494944993
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.018696802494944993
JOUBERT SYNDROME 25	0.000545554	0.018696802494944993
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.018696802494944993
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.018696802494944993
1P21.3 MICRODELETION SYNDROME	0.000545554	0.018696802494944993
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.018696802494944993
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.018696802494944993
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.018696802494944993
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.018696802494944993
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.018696802494944993
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944993
CONGENITAL VARICELLA SYNDROME	0.000545554	0.018696802494944993
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.018696802494944993
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.018696802494944993
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.018696802494944993
ALSTROM SYNDROME; ALMS	0.000545554	0.018696802494944993
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.018696802494944993
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.018696802494944993
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.018696802494944993
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.018696802494944993
DEXTROCARDIA	0.000545554	0.018696802494944993
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.018696802494944993
JOUBERT SYNDROME 8	0.000545554	0.018696802494944993
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.018696802494944993
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.018696802494944993
SEPTOOPTIC DYSPLASIA	0.000545554	0.018696802494944993
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.018696802494944993
THYROID HYPOPLASIA	0.000545554	0.018696802494944993
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.018696802494944993
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.018696802494944993
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.018696802494944993
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.018696802494944993
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.018696802494944993
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.018696802494944993
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.018696802494944993
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.018696802494944993
EVEN-PLUS SYNDROME	0.000545554	0.018696802494944993
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.018696802494944993
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.018696802494944993
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.018696802494944993
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.018696802494944993
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.018696802494944993
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.018696802494944993
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.018696802494944993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.018696802494944993
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.018696802494944993
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.018696802494944993
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.018696802494944993
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.018696802494944993
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.018696802494944993
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.018696802494944993
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.018696802494944993
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.018696802494944993
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.018696802494944993
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.018696802494944993
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.018696802494944993
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.018696802494944993
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.018696802494944993
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.018696802494944993
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.018696802494944993
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.018696802494944993
HOLOPROSENCEPHALY 11	0.000545554	0.018696802494944993
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.018696802494944993
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.018696802494944993
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.018696802494944993
TOLUENE EMBRYOPATHY	0.000545554	0.018696802494944993
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.018696802494944993
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.018696802494944993
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.018696802494944993
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.018696802494944993
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.018696802494944993
N SYNDROME	0.000545554	0.018696802494944993
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.018696802494944993
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.018696802494944993
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.018696802494944993
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.018696802494944993
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.018696802494944993
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.018696802494944993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.018696802494944993
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.018696802494944993
ATHYREOSIS	0.000545554	0.018696802494944993
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.018696802494944993
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.018696802494944993
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.018696802494944993
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.018696802494944993
AUSTRALIA ANTIGEN	0.000545554	0.018696802494944993
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.018696802494944993
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.018696802494944993
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.018696802494944993
SENIOR-LOKEN SYNDROME 9	0.000545554	0.018696802494944993
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.018696802494944993
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.018696802494944993
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.018696802494944993
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.018696802494944993
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.018696802494944993
DYSKERATOSIS CONGENITA	0.000545554	0.018696802494944993
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.018696802494944993
ALG6-CDG	0.000545554	0.018696802494944993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.018696802494944993
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.018696802494944993
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.018696802494944993
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.018696802494944993
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.018696802494944993
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.018696802494944993
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.018696802494944993
OTOFACIOCERVICAL SYNDROME	0.000545554	0.018696802494944993
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.018696802494944993
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.018696802494944993
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.018696802494944993
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.018696802494944993
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.018696802494944993
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.018696802494944993
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.018696802494944993
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.018696802494944993
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.018696802494944993
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.018696802494944993
TRISOMY 18	0.000545554	0.018696802494944993
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.018696802494944993
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.018696802494944993
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.018696802494944993
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.018696802494944993
NAVAJO NEUROHEPATOPATHY	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.018696802494944993
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.018696802494944993
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.018696802494944993
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.018696802494944993
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.018696802494944993
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.018696802494944993
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.018696802494944993
AURICULOCONDYLAR SYNDROME	0.000545554	0.018696802494944993
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.018696802494944993
ZEBRA BODY MYOPATHY	0.000545554	0.018696802494944993
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.018696802494944993
OPTIC ATROPHY 11; OPA11	0.000545554	0.018696802494944993
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.018696802494944993
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.018696802494944993
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.018696802494944993
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.018696802494944993
TYSHCHENKO SYNDROME	0.000545554	0.018696802494944993
CHAR SYNDROME	0.000545554	0.018696802494944993
FARBER DISEASE	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.018696802494944993
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.018696802494944993
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.018696802494944993
OROTIC ACIDURIA	0.000545554	0.018696802494944993
YUNIS-VARON SYNDROME	0.000545554	0.018696802494944993
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.018696802494944993
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.018696802494944993
PROPIONIC ACIDEMIA	0.000545554	0.018696802494944993
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.018696802494944993
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.018696802494944993
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.018696802494944993
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.018696802494944993
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.018696802494944993
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944993
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.018696802494944993
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.018696802494944993
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.018696802494944993
WOLMAN DISEASE	0.000545554	0.018696802494944993
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.018696802494944993
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.018696802494944993
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.018696802494944993
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.018696802494944993
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.018696802494944993
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.018696802494944993
USHER SYNDROME TYPE 1	0.000545554	0.018696802494944993
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.018696802494944993
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.018696802494944993
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.018696802494944993
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.018696802494944993
EPIDERMAL NEVUS SYNDROME	0.000545554	0.018696802494944993
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.018696802494944993
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.018696802494944993
ISOLATED PLAGIOCEPHALY	0.000545554	0.018696802494944993
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.018696802494944993
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.018696802494944993
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.018696802494944993
JOUBERT SYNDROME 7	0.000545554	0.018696802494944993
300270 ADRENOMYODYSTROPHY	0.000545554	0.018696802494944993
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.018696802494944993
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.018696802494944993
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.018696802494944993
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.018696802494944993
PELLAGRA-LIKE SYNDROME	0.000545554	0.018696802494944993
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.018696802494944993
MEIER-GORLIN SYNDROME 7	0.000545554	0.018696802494944993
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.018696802494944993
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.018696802494944993
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.018696802494944993
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944993
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.018696802494944993
MICROVILLUS INCLUSION DISEASE	0.000545554	0.018696802494944993
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.018696802494944993
HYDROXYKYNURENINURIA	0.000545554	0.018696802494944993
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018696802494944993
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.018696802494944993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.018696802494944993
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.018696802494944993
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.018696802494944993
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.018696802494944993
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.018696802494944993
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.018696802494944993
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.018696802494944993
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.018696802494944993
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.018696802494944993
JOUBERT SYNDROME 28	0.000545554	0.018696802494944993
JOUBERT SYNDROME 27	0.000545554	0.018696802494944993
JOUBERT SYNDROME 6	0.000545554	0.018696802494944993
RIGID SPINE SYNDROME	0.000545554	0.018696802494944993
CURRARINO SYNDROME	0.000545554	0.018696802494944993
BARDET-BIEDL SYNDROME 2	0.000545554	0.018696802494944993
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.018696802494944993
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.018696802494944993
MARDEN-WALKER SYNDROME	0.000545554	0.018696802494944993
SENIOR-LOKEN SYNDROME	0.000545554	0.018696802494944993
RING CHROMOSOME 12 SYNDROME	0.000545554	0.018696802494944993
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.018696802494944993
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018696802494944993
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.018696802494944993
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.018696802494944993
GERODERMA OSTEODYSPLASTICA	0.000545554	0.018696802494944993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.018696802494944993
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.018696802494944993
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.01855509099009562
PORPHYRIA	0.000541419	0.01855509099009562
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.01855509099009562
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.01855509099009562
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.01855509099009562
SJÖGREN-LARSSON SYNDROME	0.000541419	0.01855509099009562
HEREDITARY COPROPORPHYRIA	0.000541419	0.01855509099009562
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.01855509099009562
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.01855509099009562
FRAGILE X SYNDROME	0.000541419	0.01855509099009562
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.01855509099009562
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.01855509099009562
PORPHYRIA VARIEGATA	0.000541419	0.01855509099009562
FETAL GAUCHER DISEASE	0.000541419	0.01855509099009562
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.01855509099009562
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.01855509099009562
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.01855509099009562
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.01855509099009562
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.01855509099009562
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.01855509099009562
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.01855509099009562
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.01855509099009562
ENCEPHALITIS LETHARGICA	0.000541419	0.01855509099009562
EPISODIC ATAXIA TYPE 3	0.000541419	0.01855509099009562
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.01855509099009562
GRISCELLI SYNDROME TYPE 2	0.000541419	0.01855509099009562
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.01855509099009562
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.01855509099009562
NIPAH VIRUS DISEASE	0.000541419	0.01855509099009562
ADDISON DISEASE	0.000541419	0.01855509099009562
ALG2-CDG	0.000541419	0.01855509099009562
LASSA FEVER	0.000541419	0.01855509099009562
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.01855509099009562
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.01855509099009562
MOGS-CDG	0.000541419	0.01855509099009562
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.01855509099009562
FAMILIAL THROMBOCYTOSIS	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.01855509099009562
HADDAD SYNDROME	0.000541419	0.01855509099009562
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.01855509099009562
COG8-CDG	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.01855509099009562
INSULINOMA	0.000541419	0.01855509099009562
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.01855509099009562
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.01855509099009562
SYSTEMIC SCLEROSIS	0.000541419	0.01855509099009562
ADRENOMYODYSTROPHY	0.000541419	0.01855509099009562
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.01855509099009562
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.01855509099009562
TRIPLE A SYNDROME	0.000541419	0.01855509099009562
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.01855509099009562
SECONDARY SYRINGOMYELIA	0.000541419	0.01855509099009562
DPM1-CDG	0.000541419	0.01855509099009562
ALG9-CDG	0.000541419	0.01855509099009562
MPDU1-CDG	0.000541419	0.01855509099009562
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.01855509099009562
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.01855509099009562
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.01855509099009562
SCRUB TYPHUS	0.000541419	0.01855509099009562
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.01855509099009562
PFEIFFER SYNDROME TYPE 3	0.000541419	0.01855509099009562
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.01855509099009562
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.01855509099009562
ONDINE SYNDROME	0.000541419	0.01855509099009562
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.01855509099009562
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.01855509099009562
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.01855509099009562
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.01855509099009562
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.01855509099009562
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.01855509099009562
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.01855509099009562
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.01855509099009562
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.01855509099009562
GURRIERI SYNDROME	0.000541419	0.01855509099009562
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.01855509099009562
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.01855509099009562
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.01855509099009562
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.01855509099009562
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.01855509099009562
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.01855509099009562
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.01855509099009562
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.01855509099009562
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.01855509099009562
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.01855509099009562
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.01855509099009562
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.01855509099009562
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.01855509099009562
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.01855509099009562
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.01855509099009562
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.01855509099009562
THREONINEMIA	0.000541419	0.01855509099009562
THYROCEREBRORETINAL SYNDROME	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.01855509099009562
ADRENOLEUKODYSTROPHY	0.000541419	0.01855509099009562
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.01855509099009562
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.01855509099009562
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.01855509099009562
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.01855509099009562
INCONTINENTIA PIGMENTI; IP	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.01855509099009562
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.01855509099009562
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.01855509099009562
IMMUNODEFICIENCY 47	0.000541419	0.01855509099009562
FABRY DISEASE	0.000541419	0.01855509099009562
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.01855509099009562
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.01855509099009562
HHHH SYNDROME	0.000541419	0.01855509099009562
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.01855509099009562
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.01855509099009562
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.01855509099009562
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.01855509099009562
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.01855509099009562
COWDEN SYNDROME 5; CWS5	0.000541419	0.01855509099009562
COWDEN SYNDROME 6; CWS6	0.000541419	0.01855509099009562
LISSENCEPHALY 5; LIS5	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.01855509099009562
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.01855509099009562
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.01855509099009562
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.01855509099009562
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.01855509099009562
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.01855509099009562
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.01855509099009562
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.01855509099009562
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.01855509099009562
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.01855509099009562
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.01855509099009562
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.01855509099009562
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.01855509099009562
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.01855509099009562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.01855509099009562
SECKEL SYNDROME 7; SCKL7	0.000541419	0.01855509099009562
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.01855509099009562
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.01855509099009562
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.01855509099009562
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.01855509099009562
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.01855509099009562
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.01855509099009562
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.01855509099009562
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.01855509099009562
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.01855509099009562
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.01855509099009562
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.01855509099009562
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.01855509099009562
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.01855509099009562
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.01855509099009562
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.01855509099009562
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.01855509099009562
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.01855509099009562
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.01855509099009562
PERRAULT SYNDROME 3	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.01855509099009562
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.01855509099009562
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.01855509099009562
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.01855509099009562
TAY-SACHS DISEASE; TSD	0.000541419	0.01855509099009562
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.01855509099009562
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.01855509099009562
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.01855509099009562
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.01855509099009562
SNEDDON SYNDROME	0.000541419	0.01855509099009562
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.01855509099009562
STURGE-WEBER SYNDROME	0.000541419	0.01855509099009562
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.01855509099009562
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.01855509099009562
ALEXANDER DISEASE	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.01855509099009562
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.01855509099009562
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.01855509099009562
PARIETAL FORAMINA	0.000541419	0.01855509099009562
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.01855509099009562
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.01855509099009562
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.01855509099009562
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.01855509099009562
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.01855509099009562
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.01855509099009562
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.01855509099009562
CROME SYNDROME	0.000541419	0.01855509099009562
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.01855509099009562
DIAMINOPENTANURIA	0.000541419	0.01855509099009562
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.01855509099009562
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01855509099009562
DYSOSTEOSCLEROSIS	0.000541419	0.01855509099009562
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.01855509099009562
1P36 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.01855509099009562
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.01855509099009562
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.01855509099009562
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.01855509099009562
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.01855509099009562
PAPILLORENAL SYNDROME	0.000541419	0.01855509099009562
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.01855509099009562
CROUZON SYNDROME	0.000541419	0.01855509099009562
DARIER-WHITE DISEASE; DAR	0.000541419	0.01855509099009562
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.01855509099009562
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.01855509099009562
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.01855509099009562
FLYNN-AIRD SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.01855509099009562
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.01855509099009562
HUNTINGTON DISEASE; HD	0.000541419	0.01855509099009562
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.01855509099009562
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.01855509099009562
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.01855509099009562
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.01855509099009562
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.01855509099009562
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.01855509099009562
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.01855509099009562
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.01855509099009562
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.01855509099009562
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.01855509099009562
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.01855509099009562
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.01855509099009562
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.01855509099009562
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.01855509099009562
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.01855509099009562
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.01855509099009562
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.01855509099009562
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.01855509099009562
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.01855509099009562
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.01855509099009562
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.01855509099009562
NEURAMINIDASE DEFICIENCY	0.000541419	0.01855509099009562
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.01855509099009562
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01855509099009562
PHENYLKETONURIA	0.000541419	0.01855509099009562
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.01855509099009562
GITELMAN SYNDROME	0.000541419	0.01855509099009562
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.01855509099009562
RAMON SYNDROME	0.000541419	0.01855509099009562
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.01855509099009562
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.01855509099009562
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.01855509099009562
EPILEPSY-TELANGIECTASIA	0.000541419	0.01855509099009562
HYPERLYSINEMIA, TYPE I	0.000541419	0.01855509099009562
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.01855509099009562
FOUNTAIN SYNDROME	0.000541419	0.01855509099009562
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.01855509099009562
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.01855509099009562
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.01855509099009562
BERNARD-SOULIER SYNDROME	0.000541419	0.01855509099009562
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.01855509099009562
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.01855509099009562
HYPER-BETA-ALANINEMIA	0.000541419	0.01855509099009562
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.01855509099009562
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.01855509099009562
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.01855509099009562
HYPERPROLINEMIA, TYPE II	0.000541419	0.01855509099009562
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.01855509099009562
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.01855509099009562
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.01855509099009562
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.01855509099009562
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.01855509099009562
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.01855509099009562
KAPUR-TORIELLO SYNDROME	0.000541419	0.01855509099009562
KEUTEL SYNDROME; KTLS	0.000541419	0.01855509099009562
KIFAFA SEIZURE DISORDER	0.000541419	0.01855509099009562
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.01855509099009562
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.01855509099009562
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.01855509099009562
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.01855509099009562
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.01855509099009562
RAMON SYNDROME	0.000541419	0.01855509099009562
ISOLATED BILIARY ATRESIA	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.01855509099009562
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.01855509099009562
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.01855509099009562
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.01855509099009562
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.01855509099009562
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.01855509099009562
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.01855509099009562
NOCARDIOSIS	0.000541419	0.01855509099009562
PORENCEPHALY	0.000541419	0.01855509099009562
LUJO HEMORRHAGIC FEVER	0.000541419	0.01855509099009562
EBOLA HEMORRHAGIC FEVER	0.000541419	0.01855509099009562
RIFT VALLEY FEVER	0.000541419	0.01855509099009562
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.01855509099009562
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.01855509099009562
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.01855509099009562
RENPENNING SYNDROME	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.01855509099009562
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.01855509099009562
PROLACTINOMA	0.000541419	0.01855509099009562
CRONKHITE-CANADA SYNDROME	0.000541419	0.01855509099009562
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.01855509099009562
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.01855509099009562
MICROSPORIDIOSIS	0.000541419	0.01855509099009562
MOYAMOYA DISEASE	0.000541419	0.01855509099009562
MOYNAHAN SYNDROME	0.000541419	0.01855509099009562
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.01855509099009562
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.01855509099009562
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.01855509099009562
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.01855509099009562
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.01855509099009562
CONGENITAL RUBELLA SYNDROME	0.000541419	0.01855509099009562
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.01855509099009562
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.01855509099009562
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.01855509099009562
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.01855509099009562
NASU-HAKOLA DISEASE	0.000541419	0.01855509099009562
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.01855509099009562
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.01855509099009562
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01855509099009562
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.01855509099009562
TYROSINEMIA TYPE 2	0.000541419	0.01855509099009562
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.01855509099009562
TAKAYASU ARTERITIS	0.000541419	0.01855509099009562
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.01855509099009562
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
HYPOPHOSPHATASIA	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.01855509099009562
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.01855509099009562
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.01855509099009562
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.01855509099009562
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.01855509099009562
WHIM SYNDROME	0.000541419	0.01855509099009562
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.01855509099009562
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.01855509099009562
LIPOID PROTEINOSIS	0.000541419	0.01855509099009562
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.01855509099009562
HYPERPROLINEMIA TYPE 1	0.000541419	0.01855509099009562
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.01855509099009562
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.01855509099009562
MYASTHENIA GRAVIS	0.000541419	0.01855509099009562
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.01855509099009562
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.01855509099009562
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.01855509099009562
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.01855509099009562
RECURRENT ACUTE PANCREATITIS	0.000541419	0.01855509099009562
NEVUS COMEDONICUS SYNDROME	0.000541419	0.01855509099009562
LHERMITTE-DUCLOS DISEASE	0.000541419	0.01855509099009562
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.01855509099009562
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.01855509099009562
MERCURY POISONING	0.000541419	0.01855509099009562
GALACTOSIALIDOSIS	0.000541419	0.01855509099009562
THYROCEREBRORENAL SYNDROME	0.000541419	0.01855509099009562
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.01855509099009562
VIRAL HEMORRHAGIC FEVER	0.000541419	0.01855509099009562
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.01855509099009562
WHIPPLE DISEASE	0.000541419	0.01855509099009562
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.01855509099009562
WOLFRAM SYNDROME	0.000541419	0.01855509099009562
WORSTER-DROUGHT SYNDROME	0.000541419	0.01855509099009562
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.01855509099009562
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.01855509099009562
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.01855509099009562
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.01855509099009562
GLIOBLASTOMA	0.000541419	0.01855509099009562
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.01855509099009562
ADIPOSIS DOLOROSA	0.000541419	0.01855509099009562
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.01855509099009562
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.01855509099009562
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.01855509099009562
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.01855509099009562
CLASSIC HOMOCYSTINURIA	0.000541419	0.01855509099009562
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.01855509099009562
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.01855509099009562
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.01855509099009562
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.01855509099009562
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.01855509099009562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.01855509099009562
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.01855509099009562
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.01855509099009562
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.01855509099009562
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.01855509099009562
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.01855509099009562
ROMANO-WARD SYNDROME	0.000541419	0.01855509099009562
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.01855509099009562
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.01855509099009562
BETA-MANNOSIDOSIS	0.000541419	0.01855509099009562
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.01855509099009562
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.01855509099009562
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.01855509099009562
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.01855509099009562
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.01855509099009562
BOWEN-CONRADI SYNDROME	0.000541419	0.01855509099009562
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.01855509099009562
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.01855509099009562
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.01855509099009562
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.01855509099009562
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.01855509099009562
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.01855509099009562
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.01855509099009562
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.01855509099009562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.01855509099009562
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.01855509099009562
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.01855509099009562
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.01855509099009562
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.01855509099009562
PSEUDO-TORCH SYNDROME 2	0.000541419	0.01855509099009562
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.01855509099009562
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.01855509099009562
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.01855509099009562
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.01855509099009562
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.01855509099009562
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.01855509099009562
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.01855509099009562
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.01855509099009562
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.01855509099009562
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.01855509099009562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.01855509099009562
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.01855509099009562
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.01855509099009562
AICA-RIBOSIDURIA	0.000541419	0.01855509099009562
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.01855509099009562
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.01855509099009562
CRIGLER-NAJJAR SYNDROME	0.000541419	0.01855509099009562
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.01855509099009562
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.01855509099009562
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.01855509099009562
EPISODIC ATAXIA TYPE 6	0.000541419	0.01855509099009562
HARROD SYNDROME	0.000541419	0.01855509099009562
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.01855509099009562
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.01855509099009562
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.01855509099009562
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.01855509099009562
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.01855509099009562
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.01855509099009562
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.01855509099009562
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.01855509099009562
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.01855509099009562
SANJAD-SAKATI SYNDROME	0.000541419	0.01855509099009562
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.01855509099009562
4Q21 MICRODELETION SYNDROME	0.000541419	0.01855509099009562
CITRULLINEMIA TYPE I	0.000541419	0.01855509099009562
JUVENILE HUNTINGTON DISEASE	0.000541419	0.01855509099009562
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.01855509099009562
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.01855509099009562
CORNELIA DE LANGE SYNDROME	0.000541419	0.01855509099009562
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.01855509099009562
DISTAL MONOSOMY 7Q36	0.000541419	0.01855509099009562
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.01855509099009562
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.01855509099009562
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.01855509099009562
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.01855509099009562
CRISPONI SYNDROME	0.000541419	0.01855509099009562
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.01855509099009562
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.01855509099009562
KNOBLOCH SYNDROME	0.000541419	0.01855509099009562
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.01855509099009562
ROSAÏ-DORFMAN DISEASE	0.000541419	0.01855509099009562
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01855509099009562
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.01855509099009562
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.01855509099009562
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.01855509099009562
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.01855509099009562
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.01855509099009562
CENTRAL DIABETES INSIPIDUS	0.000541419	0.01855509099009562
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.01855509099009562
FRONTAL ENCEPHALOCELE	0.000541419	0.01855509099009562
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.01855509099009562
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.01855509099009562
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.01855509099009562
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.01855509099009562
